US20070055344A1 - Devices and methods for use in performing transmyocardial coronary bypass - Google Patents

Devices and methods for use in performing transmyocardial coronary bypass Download PDF

Info

Publication number
US20070055344A1
US20070055344A1 US11/594,464 US59446406A US2007055344A1 US 20070055344 A1 US20070055344 A1 US 20070055344A1 US 59446406 A US59446406 A US 59446406A US 2007055344 A1 US2007055344 A1 US 2007055344A1
Authority
US
United States
Prior art keywords
support
heart
wall
tissue
orientation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US11/594,464
Inventor
Darin Gittings
A. Sharkawy
Alan Rapacki
Gilbert Laroya
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to US11/594,464 priority Critical patent/US20070055344A1/en
Publication of US20070055344A1 publication Critical patent/US20070055344A1/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/94Stents retaining their form, i.e. not being deformable, after placement in the predetermined place
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/24Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
    • A61F2/2493Transmyocardial revascularisation [TMR] devices
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/00234Surgical instruments, devices or methods, e.g. tourniquets for minimally invasive surgery
    • A61B2017/00238Type of minimally invasive operation
    • A61B2017/00243Type of minimally invasive operation cardiac
    • A61B2017/00247Making holes in the wall of the heart, e.g. laser Myocardial revascularization
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/00234Surgical instruments, devices or methods, e.g. tourniquets for minimally invasive surgery
    • A61B2017/00238Type of minimally invasive operation
    • A61B2017/00243Type of minimally invasive operation cardiac
    • A61B2017/00247Making holes in the wall of the heart, e.g. laser Myocardial revascularization
    • A61B2017/00252Making holes in the wall of the heart, e.g. laser Myocardial revascularization for by-pass connections, i.e. connections from heart chamber to blood vessel or from blood vessel to blood vessel
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00315Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for treatment of particular body parts
    • A61B2018/00345Vascular system
    • A61B2018/00351Heart
    • A61B2018/00392Transmyocardial revascularisation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2210/00Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2210/009Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof magnetic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2220/00Fixations or connections for prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2220/0008Fixation appliances for connecting prostheses to the body
    • A61F2220/0016Fixation appliances for connecting prostheses to the body with sharp anchoring protrusions, e.g. barbs, pins, spikes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2230/00Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2230/0002Two-dimensional shapes, e.g. cross-sections
    • A61F2230/0028Shapes in the form of latin or greek characters
    • A61F2230/005Rosette-shaped, e.g. star-shaped
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2230/00Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2230/0063Three-dimensional shapes
    • A61F2230/0091Three-dimensional shapes helically-coiled or spirally-coiled, i.e. having a 2-D spiral cross-section
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2250/00Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2250/0004Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof adjustable
    • A61F2250/0007Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof adjustable for adjusting length

Definitions

  • the invention relates to treating heart disease, and more particularly systems, devices and methods for reestablishing or improving blood flow to the myocardium.
  • Coronary artery disease is currently treated by interventional procedures such as percutaneous transluminal coronary angioplasty (PTCA), atherectomy and intracoronary stenting, as well as surgical procedures including coronary artery bypass grafting (CABG).
  • PTCA percutaneous transluminal coronary angioplasty
  • CABG coronary artery bypass grafting
  • the goal of these procedures is to reestablish or improve blood flow through occluded (or partially occluded) coronary arteries, which is accomplished, for example, by enlarging the blood flow lumen of the artery or by forming a bypass that allows blood to circumvent the occlusion.
  • What procedure(s) is used typically depends on the severity and location of the blockages. When successful, these procedures restore blood flow to myocardial tissue that had not been sufficiently perfused due to the occlusion.
  • the invention provides a device and method for engaging tissue of a coronary vessel or heart wall during a cardiovascular procedure.
  • a device constructed according to this embodiment includes first and second members coupled together so as to permit relative movement.
  • a tissue engaging mechanism is coupled to the first and second members and moves between first and second positions. In the preferred embodiment, the first and second positions are collapsed and expanded orientations.
  • the tissue engaging mechanism includes at least one tissue engaging member that contacts engage body tissue when in the expanded orientation.
  • a method carried out according to this embodiment includes steps of providing a tissue support device having a tissue engaging mechanism configured to assume an expanded, tissue supporting orientation, positioning the tissue support device through the wall of a patient's heart and locating the tissue engaging mechanism adjacent tissue, and placing the tissue engaging mechanism in the expanded, tissue supporting orientation in engagement with the tissue.
  • the invention provides a device and method for supporting a wall of a vascular structure in order to access the lumen of the vascular structure.
  • a device constructed according to this embodiment includes a support structure adapted to be positioned in the lumen of a vascular structure, the support structure comprising a plurality of support elements coupled together so as to be movable relative to each other. The support elements move relative to each other to move the support structure from a collapsed orientation to an expanded orientation in order to support a wall of a vascular structure, and are sized and configured so that when the support structure is in the expanded orientation the support elements engage the wall of the vascular structure to prevent the wall from collapsing.
  • Another device constructed according to this embodiment includes an introducer having a hollow interior and an elongated support member configured to be generally coiled when in an unbiased orientation and generally straight when in a biased orientation.
  • the interior of the introducer is sized and configured to receive the elongated support member and hold the support member in the generally straight, biased orientation.
  • the elongated support member is moved from the straight, biased orientation within the interior of the introducer to the coiled, unbiased orientation upon entering the interior of the vascular structure to support the vascular structure.
  • a method carried out according to this embodiment includes steps of positioning a support within an interior of a vascular structure such that the support contacts and supports a wall of the vascular structure, and introducing a medical device into the interior of the vascular structure by passing the device through the wall of the vascular structure and through the support.
  • the invention provides a device and method for stabilizing an area of a patient's heart adjacent a coronary vessel.
  • a device constructed according to this embodiment includes a base configured to be positioned adjacent a coronary vessel of a patient's heart, the base having at least one opening for accessing the coronary vessel.
  • At least one tissue engaging element is coupled to the base so as to be movable with respect to the base, the tissue engaging element having a portion configured to securely engage the wall of a patient's heart in order to stabilize the wall of the heart upon moving the tissue engaging element with respect to the base.
  • An actuator is provided for imparting relative movement to the base and the tissue engaging element in order to stabilize the heart while accessing the coronary vessel through the opening in the base.
  • the invention provides a conduit for placing a coronary vessel of a patient's heart in communication with a heart chamber.
  • the conduit is in the form of a tubular element including first and second portions having different cross-sectional sizes and a bore defining a blood flow path.
  • the cross-section of the first portion of the tubular element is larger than the cross-section of the second portion such that the tubular element is generally funnel-shaped, and the first and second portions of the tubular element are generally aligned so that the bore defines a generally straight blood flow path.
  • the invention provides a conduit for communicating a chamber of a patient's heart with a coronary vessel.
  • the conduit is in the form of an expandable stent including first and second portions having different cross-sectional sizes when the stent is expanded.
  • Each of the first and second portions of the stent includes strut members disposed along a first direction when the stent is unexpanded and along a second direction when the stent is expanded, the second direction being transverse to the first direction.
  • the strut members of the first portion are longer than the strut members of the second portion so that the stent is generally funnel-shaped when expanded.
  • the invention provides a conduit is in the form of an expandable tubular element having first and second portions with different cross-sectional sizes.
  • This tubular element is preferably a coronary stent constructed so that the first and second portions are disposed in an orientation that provides the stent with maximum radial strength when expanded.
  • the invention provides a conduit for placing a coronary vessel in communication with a heart chamber, the conduit including a vessel support mechanism configured to contact and support the vessel wall when the conduit is positioned in the heart wall.
  • FIG. 1 is a schematic view of a patient prepared to undergo a cardiovascular surgical procedure, the patient's heart being exposed via a retractor positioned in a thoracotomy formed in the patient's chest;
  • FIG. 2 is a perspective view of the heart shown in FIG. 1 , wherein a portion of the heart wall is broken away for clarity;
  • FIG. 2A is an enlarged view of a portion of FIG. 2 ;
  • FIGS. 3A-3B are perspective views showing a tissue engaging device constructed according to one embodiment of the invention, the device being shown in collapsed and expanded orientations, respectively;
  • FIGS. 4A-4B are elevation views, in section, illustrating one preferred construction of a tissue engaging device according to the embodiment of FIGS. 3A-3B , wherein the device is shown being used to engage the heart wall shown in FIGS. 2-2A ;
  • FIGS. 5A-5B are elevation views, in section, illustrating another preferred construction of a tissue engaging device according to the embodiment of FIGS. 3A-3B , wherein the device is shown being used to engage the heart wall shown in FIGS. 2-2A ;
  • FIGS. 6A-6C are elevation views, in section, sequentially illustrating a vessel support device constructed according to another embodiment of the invention being used to support the wall of a vascular structure;
  • FIG. 7 is a perspective view of a vessel support device constructed according to an alternative embodiment of the invention, the device being shown positioned in the interior of a vascular structure;
  • FIGS. 8A-8B are elevation views, in section, sequentially illustrating the device shown in FIG. 7 being used to support a coronary artery of the heart shown in FIGS. 2-2A ;
  • FIG. 9 is a perspective view of a vessel support device constructed according to another alternative embodiment of the invention, the device being shown positioned in the interior of a vascular structure;
  • FIGS. 10A-10B are elevation views, in section, sequentially illustrating the device shown in FIG. 9 being used to support a coronary artery of the heart shown in FIGS. 2-2A ;
  • FIGS. 11A-11B are plan views of a tissue engaging device constructed according to another embodiment of the invention, wherein the device is shown engaging the wall of the heart shown in FIGS. 2-2A in non-retracting and retracting orientations, respectively;
  • FIGS. 12A-12B are elevation views, in section, taken along lines A-A in FIGS. 1A-1B ;
  • FIG. 13 is an elevation view, in section, of an alternative tissue engaging device constructed according to the embodiment shown in FIGS. 12A-12B ;
  • FIGS. 14A-14B are elevation views of a tapered balloon forming part of another embodiment of the invention, wherein the balloon is shown in its collapsed and expanded orientations, respectively;
  • FIGS. 15A-15B are elevation views of an expandable conduit mounted on the tapered balloon shown in FIGS. 14A-14B , the conduit being shown in its collapsed and expanded orientations, respectively;
  • FIG. 16 is an elevation view, in section, of a portion of a heart wall and coronary vessel in which the conduit shown in FIG. 15A-15B has been positioned;
  • FIGS. 17A-17B are elevation views showing a conduit constructed according to still another embodiment of the invention, wherein the conduit has a cross-sectional size that varies over its length;
  • FIG. 18 is a perspective view of another embodiment of the invention providing a conduit for placing a coronary vessel in communication with a heart chamber while internally supporting the interior of the vessel;
  • FIGS. 19A-19C are schematic representations of a preferred application for the conduit shown in FIG. 18 ;
  • FIG. 20 is a perspective view of an alternative embodiment of a conduit for placing a coronary vessel in communication with a heart chamber while internally supporting the interior of the vessel;
  • FIG. 21 is a perspective view of another alternative embodiment of a conduit for placing a coronary vessel in communication with a heart chamber while internally supporting the interior of the vessel;
  • FIG. 22 is a perspective view of yet another alternative embodiment of a conduit for placing a coronary vessel in communication with a heart chamber while internally supporting the interior of the vessel.
  • FIG. 1 schematically depicts a patient who has been prepared to undergo a cardiovascular surgical procedure.
  • a thoracotomy T formed in the patient's chest by making an incision between two ribs (not shown) provides access to the thoracic cavity.
  • a retractor such as the rib retractor R shown in FIG. 1 , may be used to spread the ribs and increase access to the heart H and great vessels.
  • the retractor is preferably of a type that in addition to spreading the sides of the incision along a first plane, also raises one side of the incision with respect to the other side to increase the working space around the heart.
  • Any suitable retractor may be used, for example, one of the commercially available rib retractors currently used in minimally invasive cardiac surgery. As shown in FIG.
  • the retractor R provides considerable access to the surfaces of the heart H and great vessels including the aorta A.
  • the left side of the heart as well as the left coronary artery LCA is easily accessible via the thoracotomy T ( FIG. 1 ).
  • FIG. 2 is an anterior view of a heart 10 showing the left ventricle 12 , right ventricle 14 , right atrium 16 , aorta 18 , pulmonary trunk 20 and pulmonary veins 22 .
  • the heart 10 is in diastole, or the relaxed phase of the heart cycle, so the aortic valve 24 is shown closed.
  • the left coronary artery 26 including the circumflex branch 28 and the left anterior descending branch (LAD) 30 , is visible in this view, as is the right coronary artery 32 .
  • LAD left anterior descending branch
  • the coronary arteries 26 , 28 , 30 , 32 run along the heart wall 34 and deliver oxygenated blood to the tissue comprising the heart wall (epicardium, myocardium and endocardium) while the coronary veins run alongside the arteries and return blood to the coronary sinus (not shown).
  • the tissue comprising the heart wall (epicardium, myocardium and endocardium) while the coronary veins run alongside the arteries and return blood to the coronary sinus (not shown).
  • FIGS. 2-2A show a portion of the heart wall 34 disposed between the left ventricle 12 and the LAD 30 , as well as the inner and outer walls 38 , 40 of the LAD 30 .
  • the devices and methods of the different embodiments of the invention are illustrated and described in connection with their use on the portion of the heart 10 shown in FIG. 2A . It will be understood, however, that such description is for explanatory purposes and exemplifies only one application for the invention.
  • FIGS. 3A-3B illustrate a first embodiment of the invention that provides a device and method for engaging tissue of a coronary vessel or heart wall during a cardiovascular procedure.
  • a preferred device is indicated generally by the reference numeral 100 and includes first and second relatively movable members and a tissue engaging mechanism coupled to the members.
  • the members comprise first and second coaxial shafts 102 , 104 coupled to a tissue engaging mechanism 106 .
  • the tissue engaging mechanism 106 is coupled to the shafts 102 , 104 so that relative movement imparted to the shafts results in the mechanism 106 moving between a collapsed orientation ( FIG. 3A ) and an expanded, tissue engaging orientation ( FIG. 3B ).
  • the first shaft 102 has a distal end 108 which is secured to a distal end 110 of the shaft 104 .
  • the tissue engaging mechanism 106 is disposed adjacent the distal ends 108 , 110 of the shafts 102 , 104 and comprises one or more tissue engaging members 112 which move radially outward when the mechanism is in the expanded orientation.
  • Each tissue engaging member 112 has one end 114 fixed to the distal end 108 of shaft 102 at 116 , and another end 118 fixed to the shaft 104 at 120 .
  • FIG. 3A shows the tissue engaging mechanism 106 in its collapsed orientation with the members 112 generally straight.
  • FIG. 3B shows the tissue engaging mechanism 106 in its expanded orientation in which the members 112 extend outward in a radial direction.
  • the components of the device 100 may be formed of any suitable material.
  • the orientation of the tissue engaging mechanism 106 is controlled by imparting relative movement to the shafts 102 , 104 .
  • the device 100 is preferably introduced into a coronary vessel or heart wall with the tissue engaging mechanism 106 in the low profile orientation shown in FIG. 3A .
  • the device 100 may have a sharpened tip as shown, or it may have a dilating portion that dilates a previously-formed incision.
  • the tissue engaging mechanism 106 is moved to the expanded orientation shown in FIG. 3B in order to engage tissue. This may be achieved by moving the inner shaft 102 in the direction of the arrows with respect to the outer shaft 104 , which moves the ends 114 , 118 of the tissue engaging members 112 toward each other to expand the mechanism 106 .
  • the device 100 may be used to perform any of various functions, for example, to support, retract or stabilize tissue during a cardiovascular procedure.
  • FIGS. 4A-4B show one application of the device 100 , namely, to engage the tissue of the wall of a patient's heart.
  • the device 100 is inserted through a coronary vessel such as LAD 30 and the heart wall 34 with the tissue engaging mechanism 106 in its collapsed orientation.
  • the shafts 102 , 104 are moved with respect to each other to expand the tissue engaging mechanism 106 to the position shown in FIG. 4A .
  • the expanded tissue engaging mechanism 106 may then be used to engage and support the heart wall 34 to facilitate carrying out a cardiovascular procedure, for example, placing a conduit (not shown) in the heart wall to place the coronary vessel in communication with the heart chamber, or forming a channel in the heart wall to place the coronary vessel in communication with the heart chamber.
  • FIGS. 5A-5B show another application of the device 100 , namely, to engage the tissue of the wall of a coronary vessel.
  • the device 100 is introduced with the tissue engaging mechanism 106 in its collapsed orientation, the device being passed through the heart wall 34 and then the inner wall 38 of the LAD 30 .
  • the shafts 102 , 104 are moved with respect to each other to expand the tissue engaging mechanism 106 to the orientation shown in FIG. 5A .
  • the tissue engaging mechanism 106 may then be used to engage and support the wall 38 of the LAD and the heart wall 34 to facilitate carrying out a cardiovascular procedure. Examples of such procedures include placing a conduit (not shown) in the heart wall to place the coronary vessel in communication with the heart chamber, and forming a channel in the heart wall to place the coronary vessel in communication with the heart chamber.
  • the device 100 may have a second tissue engaging mechanism 106 A so that a body of tissue may be sandwiched between the two mechanisms 106 , 106 A for added stability.
  • FIGS. 6A-6C depict another embodiment of the invention that provides a device and method for supporting a wall of a vascular structure in order to access the lumen of the vascular structure.
  • One device constructed according to this embodiment is designated generally by the reference numeral 130 and includes an elongated support member 132 and an introducer 134 .
  • the introducer has a bore 136 that is configured to receive the support member 132 , as shown in FIG. 6A and preferably has a small diameter in order to minimize the size of the opening in the vascular structure, which in the illustrated embodiment is a coronary vessel and, in particular, LAD 30 .
  • the elongated support member 132 is preferably constructed so as to expand when in an unbiased orientation, i.e., when it is not constrained by the introducer 134 .
  • the support member 132 is constructed to assume a coiled shape when in the unbiased orientation, for example, the helical configuration shown in FIG. 6B .
  • the support member 132 is in a biased orientation and assumes a generally straight shape within the bore 136 of the introducer.
  • an end 138 of the introducer 134 is positioned against the exterior of the wall 40 of the LAD with the elongated support member 132 disposed within the introducer 134 .
  • the end 138 of the introducer 134 may be passed through the wall 40 into the lumen 42 of the LAD 30 . If used in this manner, the support member 132 does not need to pierce the tissue of the vascular structure; if used as shown in solid lines in FIG. 6A , an end 140 of the support member 132 is preferably sharpened to pierce through the wall of the vascular structure.
  • the elongated support member 132 is fed through the introducer 134 into the lumen 42 of the LAD 30 .
  • the support member 132 forms a coil 142 as it exits the introducer 134 , as shown in FIG. 6B .
  • the support member is constructed so that the coil 142 has a size that contacts and distends slightly the LAD 30 , thereby providing support to the LAD to allow precise entry into the lumen 42 of the LAD.
  • a medical device may then be inserted through the wall of the vascular structure and the support member.
  • FIG. 6C shows a medical device 144 inserted through the wall 40 of the LAD 30 and through the coil 142 . The device 144 is then removed upon completing the procedure; the elongated support member 132 may then be removed from the LAD 30 by retracting the member back into the bore 136 of the introducer 134 .
  • the elongated support member 132 may be formed of any suitable material having sufficient memory to assume an expanded configuration when unbiased, such as spring wire or nitinol.
  • the support member 132 could be formed of a length of nitinol wire having an approximate diameter of 0.007 inch that has been wrapped on a suitable mandrel (not shown), such as a stainless steel rod having an approximate diameter of 0.060 inch.
  • the mandrel and wire are then heated to set the shape in the wire which, per se, is known in the art.
  • the mandrel may have two apertures that receive the ends of the nitinol wire and a relief section that causes the end 140 of the support member to roll inward toward the interior of the coil 142 , which minimizes the risk of the end 140 damaging tissue.
  • the device 130 may be used to support a vascular structure independently of carrying out a medical procedure.
  • the device 130 could be used to introduce the support member 132 into a coronary artery in order to stent the artery, the coil 142 remaining in place in the same manner as a conventional coronary stent.
  • FIGS. 7 and 8 A- 8 B depict an alternative embodiment of a device and method for supporting a wall of a vascular structure in order to access the lumen of the vascular structure.
  • the device is indicated generally by the reference numeral 160 and is configured to be placed in a collapsed orientation for introduction into a vascular structure and then expanded to contact and support the wall of the structure.
  • the device 160 comprises a support structure 162 removably retained in an introducer 164 .
  • the illustrated support structure 162 comprises a plurality of struts 166 that form a basket-like member when moved out of the introducer 164 .
  • the struts 166 may be in the form of resilient wires that move away from each other as the support structure 162 exits the introducer 164 , the wires extending between proximal and distal portions 168 , 170 of the support structure.
  • the introducer 164 may be a sheath or sleeve sized and configured to at least partially surround the support structure 162 and hold the struts 166 together.
  • the respective components may be formed of suitable materials, such as spring wire and a polymer sleeve.
  • FIG. 7 shows one preferred use of the device 160 wherein the device is inserted through an opening in a vascular structure, such as incision 44 in LAD 30 .
  • a vascular structure such as incision 44 in LAD 30 .
  • the device may be passed through a peripheral vessel to a desired location within a vascular structure, and then expanded within the vascular structure by moving the support structure out of the introducer.
  • FIG. 8A the device is passed through the incision 44 and into the lumen 42 of the LAD 30 .
  • the introducer 164 is then retracted over the proximal portion 168 of the support structure which results in the struts 166 moving away from each other to contact and support the wall of LAD 30 .
  • various medical devices may then be introduced through the wall of the vascular structure and through the support structure 162 .
  • the introducer 164 is slid back over the struts 166 to collapse the support structure 162 , which allows the device 160 to be removed through the incision 44 .
  • FIGS. 9 and 10 A- 10 B illustrate another alternative embodiment of a device and method for supporting a wall of a vascular structure in order to access the lumen of the vascular structure.
  • the device has a construction somewhat similar to the device 160 in FIGS. 7 and 8 A- 8 B.
  • the device is indicated generally by the reference numeral 180 in FIG. 9 and is configured to be placed in a collapsed orientation for introduction into a vascular structure and then expanded to contact and support the wall of the structure.
  • the device 180 comprises a support structure 182 removably retained in an introducer 184 .
  • the illustrated support structure 182 includes a plurality of struts 186 which may be in the form of resilient wires that move away from each other as the support structure exits the introducer 184 .
  • the struts 186 may be joined at their proximal ends 188 and preferably have distal ends 190 with a non-traumatic configuration to prevent tissue damage.
  • the introducer 164 may be a sheath or sleeve sized and configured to at least partially surround the support structure 162 to hold the struts 186 together.
  • the materials used in the embodiment of FIG. 7 may be used in this embodiment.
  • the device 180 is passed through the incision 44 and into the lumen 42 of the LAD 30 , and the introducer 184 is then retracted to allow the struts 186 to move away from each other.
  • various medical devices may then be introduced through the wall of the vascular structure and through the support structure 162 .
  • vascular support devices and methods illustrated in the drawings are only preferred embodiments of the invention.
  • This aspect of the invention encompasses supporting the wall of a vascular structure in order to allow precise entry into the lumen, which may be relatively difficult if the wall of the vascular structure is collapsed.
  • an alternative design utilizes an expandable support that may be in the form of a stent having one or more openings to allow passage of medical devices into the lumen of the vascular structure.
  • the stent could have any desired coverage area with openings provided between adjacent stent elements or formed by removing portions of the stent elements.
  • Another alternative design comprises a device in the form of a member configured to rest on the exterior of the vascular structure to provide access into the lumen of the structure.
  • the device may have a distal portion shaped somewhat complementarily to the vascular structure to closely engage same.
  • the distal portion could include a concave recess that receives the vascular structure when the device is rested on surrounding tissue.
  • the device preferably has a bore that opens into the recess so that a medical device inserted into the bore passes through the wall of the vascular structure.
  • the vessel support devices are shown introduced into the vessel through the wall close to or at the area of the vessel that is supported.
  • the support devices could be positioned in an alternative manner, for example, by passing the device through the artery lumen from a location downstream of the area that is supported.
  • FIGS. 11A-11B and 12 A- 12 B show another embodiment of the invention that provides devices and methods for stabilizing an area of a patient's heart adjacent a coronary vessel.
  • the illustrated device is indicated generally by the reference numeral 200 and comprises a base 202 configured to be positioned adjacent a coronary vessel of a patient's heart.
  • the base 202 has at least one opening 204 which provides access to the coronary vessel, which, in the illustrated embodiment, is the LAD 30 .
  • the device 200 also includes at least one, and preferably a plurality, of tissue engaging elements 206 coupled to the base 202 so as to be movable with respect thereto.
  • Each tissue engaging element 206 has an end 208 configured to securely engage the tissue of a patient's heart in order to stabilize the heart, and an end 210 coupled to the base 202 .
  • Each end 210 is pivotally attached to the base 202 by a pivot pin 212 .
  • the base 202 has a plurality of recesses 214 each of which mounts an end 210 of a tissue engaging element 206 .
  • Each of the recesses 214 has a cam surface 216 that engages the end 210 of a tissue engaging element 206 upon actuating the device in order to retract the cardiac tissue and stabilize the heart.
  • the device 200 has an actuator to drive the tissue engaging elements 206 and retract tissue.
  • the actuator may comprise rotating the base 202 so as to drive the cam surfaces 216 of recesses 214 against the ends 210 of the tissue engaging elements 206 .
  • FIG. 11A shows the device 200 before actuation;
  • FIG. 11B shows the device after the base 202 has been rotated.
  • Each tissue engaging element 206 is preferably biased to the position of FIGS. 11 A and 12A by suitable means, such as tension springs extending between the base 202 and the tissue engaging elements 206 .
  • the components of the device 200 may be made from any suitable materials; for example, the base may comprise a polymer
  • FIGS. 11A-11B and 12 A- 12 B show one possible application for the device 200 , retracting the wall of a heart adjacent a coronary vessel to stabilize vessel.
  • the device 200 is positioned on the heart wall 34 so that the opening 204 overlies the LAD 30 .
  • the ends 208 of the tissue engaging elements 206 are engaged with the tissue of the heart wall 34 by any suitable means. As shown in FIGS. 12A-12B , the ends 208 may simply have sharp tips which are passed into the tissue to engage the elements with the heart wall.
  • the ends 208 of the tissue engaging elements 206 may have a mechanism for more securely engaging the tissue, such as expandable members 218 .
  • the expandable members 218 may be constructed as described above with respect to the embodiment of FIGS. 3A-3B , thereby allowing the ends 208 to be collapsed, for passage through the heart wall and then expanded once through the wall in order to positively secure the device 200 to the tissue.
  • the members 218 may be expanded by moving one shaft relative to another as described above.
  • the base 202 is rotated as described above,. which drives the tissue engaging elements relative to the base and the tissue. This action tensions the tissue of the heart wall 34 to retract the wall and stabilize the heart in the area of the coronary vessel, as shown in FIGS. 11B and 12B .
  • the coronary vessel which is the LAD 30 in the Figures, is stabilized so that subsequent procedures may be carried out on a relatively stable site.
  • the device 200 may be used to stabilize the heart while passing a conduit delivery device through the vessel and the heart wall in order to place the vessel in communication with a heart chamber.
  • a conduit for placing a coronary vessel of a patient's heart in communication with a heart chamber.
  • the conduit comprises a tubular element including first and second portions having different cross-sectional sizes, and a bore defining a blood flow path.
  • the cross-section of the first portion of the tubular element is larger than the cross-section of the second portion of the tubular element.
  • the different cross-sectional configurations are selected to produce a tubular element that is generally funnel-shaped.
  • the first and second portions of the tubular element are generally aligned and the bore defines a generally straight blood flow path.
  • the tubular element is an expandable stent including a bore defining a blood flow path and first and second portions, the first and second portions having different cross-sectional sizes when the stent is expanded.
  • the first and second portions of the stent are preferably constructed to provide the stent with maximum radial strength when expanded.
  • FIGS. 14A-14B and 15 A- 15 B show one preferred system for placing a funnel-shaped conduit in a patient's heart wall to communicate a coronary vessel with a heart chamber.
  • the system includes a balloon 220 and a conduit 222 .
  • the balloon 220 is generally straight over its length when unexpanded ( FIG. 14A ); however, when expanded the balloon 220 assumes a tapered orientation with a large end 224 and a small end 226 ( FIG. 14B ).
  • the conduit 222 is also preferably straight over its length when supported by the balloon 220 in a collapsed orientation ( FIG. 15A ) and funnel shaped when expanded by the balloon ( FIG. 15B ).
  • a tapered balloon is not necessary to expand a tapered or funnel-shaped stent.
  • a straight balloon could be used to expand a stent constructed to assume a funnel-shaped configuration, with the inflated size of the balloon preferably being sufficient to fully expand the large end of the stent.
  • FIG. 16 depicts an exemplary application of the conduit 202 shown in FIGS. 15A-15B .
  • the conduit 202 is shown positioned in a heart wall 34 with a large diameter end 228 located in a heart chamber such as the left ventricle 12 and a small diameter end 230 located in a coronary vessel such as LAD 30 .
  • a coronary vessel such as LAD 30 .
  • the shape, size and orientation of the conduit 202 in the heart wall and coronary vessel may be varied from that shown in FIG. 16 .
  • the taper of the conduit wall may be non-continuous or more gradual or severe than that shown in the Figures, or either end of the conduit may be flush or within the heart wall.
  • the conduit may be a rigid or expandable tubular element.
  • FIGS. 17A-17B show one preferred funnel-shaped stent 240 that includes a plurality of stent elements in the form of struts 242 that move relative to each other as the stent moves to its expanded orientation.
  • the struts 242 are joined at nodes 244 which move along with the struts as the stent 240 moves to its expanded orientation.
  • a plurality of open areas are defined between the struts 242 through which blood may flow.
  • FIG. 17A shows the stent 240 in its collapsed orientation.
  • the stent 240 comprises a first portion 246 , a second portion 248 and a third portion 250 .
  • These three portions 246 , 248 , 250 are designed so that upon expansion they have different diameters or cross-sectional dimensions. This may be achieved by using different length struts 242 for the respective portions 246 , 248 , 250 .
  • the relative dimensions of the struts (and thus the relative size of the expanded portions formed by the struts) may be varied to achieve different sizes and shapes.
  • the illustrated stent 240 is constructed so that the first portion 246 expands to the smallest diameter while the third portion 250 expands to the largest diameter.
  • the second portion 248 expands to a middle diameter that tapers between the portions 246 , 250 .
  • the struts 242 of the stent 240 preferably assume a maximum load supporting position when fully expanded.
  • the stent 240 may be used in various applications, including forming a blood flow path between a coronary vessel and a heart chamber.
  • the stent 240 (or another conduit constructed according to this embodiment of the invention) may be used as a coronary stent to improve blood flow through a coronary artery.
  • the stent 240 would be introduced into a peripheral vessel and guided to the desired artery by conventional means.
  • FIGS. 18 and 19 A- 19 C show another embodiment of the invention providing a conduit for placing a coronary vessel in communication with a heart chamber, the conduit including a mechanism for internally supporting the interior of the vessel.
  • FIG. 18 shows a conduit 260 in the form of a rigid, tubular element having a first end 262 and a second end 264 .
  • the conduit 260 has a bore 266 passing therethrough that defines a blood flow path.
  • a mechanism 268 is provided to support the wall of a coronary vessel with which the conduit 260 communicates.
  • the mechanism 268 includes a pair of support arms 270 preferably in the form of flexible members made from any suitable material, such as stainless steel, nitinol, polymers, etc.
  • a pair of support arms 270 is shown; however, any desired number of arms may be used.
  • Each support arm 270 is secured to the conduit 260 at 272 , for example, by welding, brazing or adhesive.
  • the support arms 270 may be integrally formed as part of the conduit 260 .
  • the support arms 270 are provided with vessel supporting portions 274 which may be formed by rounded lengths of wire 276 , as shown.
  • the support arms 270 may be folded against the wall of the conduit 260 so that the conduit assumes a relatively low profile position.
  • the conduit 260 is then passed through an opening in the wall of a coronary vessel such as the LAD 30 ( FIG. 19A ).
  • the support arms 270 may be constrained against the conduit 260 manually, with an instrument, or with a removable sheath or cover.
  • the conduit 260 is delivered into the lumen 42 of the LAD and the heart wall 34 an amount sufficient to place all (or substantially all) of the support arms 270 inside the outer wall 40 of LAD 30 ( FIG. 19B ). At this point the support arms 270 spring out to the position shown in FIG.
  • the conduit is preferably configured so that when the support arms are in this position the conduit end 262 extends into the left ventricle 12 while the conduit end 264 extends into the LAD 30 .
  • FIG. 20 shows an another embodiment of a conduit with a vessel supporting mechanism.
  • the conduit is designated 280 and preferably is a rigid tubular element as in the previous embodiment.
  • the conduit 280 has a mechanism 282 that supports the wall of a coronary vessel in which the conduit is placed.
  • the support mechanism 282 includes three support arms 284 in the form of hoops made from any suitable material, as discussed above.
  • the support arms 284 are also preferably flexible and secured to the conduit 280 by welding, brazing or adhesive.
  • the support arms 284 have vessel supporting portions 286 that contact and may slightly distend the vessel wall. While three arms 284 are shown, any desired number may of course be used.
  • FIG. 21 shows still another embodiment of a conduit with a vessel supporting mechanism.
  • the conduit is designated 290 and preferably is a rigid tubular element as in the previous embodiments.
  • the conduit 290 is provided with a mechanism 292 for supporting the wall of a coronary vessel.
  • the vessel support mechanism 292 includes a first pair of support arms 294 and a second pair of support arms 296 in the form of tabs made from any suitable material, as discussed above.
  • the support arms 294 extend generally along the longitudinal axis of the conduit 290 and are adapted to contact the outer wall of a coronary vessel, while the support arms 296 extend radially from the conduit 290 and are adapted to contact the inner wall of the vessel.
  • the support arms 294 , 296 are preferably integrally formed with the conduit 290 and are flexible to assume a low profile position. It will be noted that the support arms 294 , 296 could be separate members secured to the conduit by suitable means such as welding, brazing or adhesive. Also, although three arms 284 are shown, any desired number may be used.
  • FIG. 22 shows yet another embodiment of a conduit with a vessel supporting mechanism.
  • the conduit is designated 300 and, instead of being a rigid tubular element as in the previous embodiments, is an expandable tubular element, for example, a coronary stent.
  • the conduit 300 has stent elements in the form of struts 302 joined at nodes 304 .
  • the conduit 300 may be formed substantially in the same manner as the stent 240 in FIGS. 17A-17B .
  • the conduit 300 is provided with a mechanism 306 for supporting the wall of a coronary vessel.
  • the vessel support mechanism 306 in this embodiment includes a pair of extensions 308 that are preferably formed as an integral part of the stent struts 302 .
  • the extensions 308 extend generally along the longitudinal axis of the conduit 290 so as to contact the outer wall of a coronary vessel, thereby supporting the wall in the manner discussed above.
  • the ends 310 of the extensions 308 may be unattached, as shown, or attached.
  • the conduit 300 may be mounted on a balloon or other expandable member (not shown) in a collapsed orientation for introduction into the coronary vessel and the heart wall.
  • the extensions 308 can be loaded on the balloon with the remaining portion of the conduit 300 . Once properly positioned in the heart wall, the balloon is inflated to expand the conduit 300 to the orientation shown in FIG. 22 . It should be recognized that this embodiment of the invention may be carried out using any expandable conduit, the particular stent shown in FIG. 22 representing only one possible construction. Also, the extensions 308 could be separate members secured to the conduit 300 by suitable means such as welding, brazing or adhesive. Finally, although two extensions 308 are provided on the illustrated conduit, any number of extensions may be used.
  • conduit refers to any structure that is capable of conveying fluid from one point to another, for example, a tubular element with two or more open ends.
  • the conduits in the illustrated embodiments are merely exemplary.
  • the conduit could be a rigid, flexible or expandable tubular element formed of metal, polymers or composite materials having solid or perforated walls.
  • the conduit could be straight over its length with the ends aligned or the ends could be offset, the exterior surface of the conduit may be treated to enhance fixation of the conduit in the heart wall, and the conduit may or may not include a valve or other flow controlling mechanism.
  • a conduit constructed according to the invention may be used to deliver various pharmaceutical substances, such as angiogenic growth factors or other substances that aid in the perfusion of surrounding myocardial tissue.
  • LAD 30 illustrated in the Figures is but one example of a possible vessel which may be placed in communication with a heart chamber.
  • the LAD 30 is placed in communication with a heart chamber that contains blood, which, in the illustrated embodiments, is the left ventricle 12 . It will be understood, however, that the invention may be used to place a conduit in communication with any source of blood (arterial or venous), for example, another heart chamber such as the left atrium, or the aorta, pulmonary veins, etc.
  • a source of blood arterial or venous
  • another heart chamber such as the left atrium, or the aorta, pulmonary veins, etc.
  • the various devices of the invention incorporated in the illustrated embodiments may be used together or separately, and the methods may be modified, carried out by combining particular steps, or varying the sequence of steps.
  • the embodiments may be used in various types of procedures, for example, the surgical approach depicted in FIG. 1 , an open surgical procedure including a median sternotomy, or a minimally invasive procedure utilizing one or more relatively small access openings or ports. Endoscopes or thoracoscopes may be used for visualization if the procedure is truly minimally invasive.
  • an endovascular approach may be used to guide various inventive devices to the heart through the patient's vascular system to the heart, for example, by introducing the devices into a peripheral vessel such as the femoral artery.
  • the different embodiments may be used in beating heart procedures, stopped-heart procedures utilizing cardiopulmonary bypass (CPB), or procedures during which the heart is intermittently stopped and started.
  • CPB cardiopulmonary bypass

Abstract

Devices and methods utilized in performing transmyocardial coronary bypass include retractors used to engage and support myocardial tissue, and mechanisms for supporting coronary vessels so as to allow precise entry into a vessel lumen. In addition, various conduits are provided having a configuration that permits their positioning in a heart wall to place a coronary vessel in communication with a heart chamber.

Description

    CROSS-REFERENCE TO RELATED APPLICATIONS
  • This application is a continuation-in-part of application Ser. No. 09/023,492, filed Feb. 13, 1998, and entitled “Methods and Devices Providing Transmyocardial Blood Flow to the Arterial Vascular System of the Heart,” the entire subject matter of which application is incorporated herein by reference.
  • BACKGROUND OF THE INVENTION
  • 1. Field of the Invention
  • The invention relates to treating heart disease, and more particularly systems, devices and methods for reestablishing or improving blood flow to the myocardium.
  • 2. Description of Related Art
  • Despite the considerable advances that have been realized in cardiology and cardiovascular surgery, heart disease remains the leading cause of death throughout much of the world. Coronary artery disease, or arteriosclerosis, is the single leading cause of death in the United States today. As a result, those in the cardiovascular field continue the search for new and improved treatments.
  • Coronary artery disease is currently treated by interventional procedures such as percutaneous transluminal coronary angioplasty (PTCA), atherectomy and intracoronary stenting, as well as surgical procedures including coronary artery bypass grafting (CABG). The goal of these procedures is to reestablish or improve blood flow through occluded (or partially occluded) coronary arteries, which is accomplished, for example, by enlarging the blood flow lumen of the artery or by forming a bypass that allows blood to circumvent the occlusion. What procedure(s) is used typically depends on the severity and location of the blockages. When successful, these procedures restore blood flow to myocardial tissue that had not been sufficiently perfused due to the occlusion.
  • Technological and procedural advances have improved the results obtained by the medical procedures now used to treat heart disease, and in particular coronary artery disease. There is, however, still much room for improvement. For that reason there remains a need in the art for new and improved systems, devices and methods for treating heart disease such as arteriosclerosis.
  • SUMMARY OF THE INVENTION
  • In one embodiment, the invention provides a device and method for engaging tissue of a coronary vessel or heart wall during a cardiovascular procedure. A device constructed according to this embodiment includes first and second members coupled together so as to permit relative movement. A tissue engaging mechanism is coupled to the first and second members and moves between first and second positions. In the preferred embodiment, the first and second positions are collapsed and expanded orientations. The tissue engaging mechanism includes at least one tissue engaging member that contacts engage body tissue when in the expanded orientation.
  • A method carried out according to this embodiment includes steps of providing a tissue support device having a tissue engaging mechanism configured to assume an expanded, tissue supporting orientation, positioning the tissue support device through the wall of a patient's heart and locating the tissue engaging mechanism adjacent tissue, and placing the tissue engaging mechanism in the expanded, tissue supporting orientation in engagement with the tissue.
  • In another embodiment, the invention provides a device and method for supporting a wall of a vascular structure in order to access the lumen of the vascular structure. A device constructed according to this embodiment includes a support structure adapted to be positioned in the lumen of a vascular structure, the support structure comprising a plurality of support elements coupled together so as to be movable relative to each other. The support elements move relative to each other to move the support structure from a collapsed orientation to an expanded orientation in order to support a wall of a vascular structure, and are sized and configured so that when the support structure is in the expanded orientation the support elements engage the wall of the vascular structure to prevent the wall from collapsing.
  • Another device constructed according to this embodiment includes an introducer having a hollow interior and an elongated support member configured to be generally coiled when in an unbiased orientation and generally straight when in a biased orientation. The interior of the introducer is sized and configured to receive the elongated support member and hold the support member in the generally straight, biased orientation. The elongated support member is moved from the straight, biased orientation within the interior of the introducer to the coiled, unbiased orientation upon entering the interior of the vascular structure to support the vascular structure.
  • A method carried out according to this embodiment includes steps of positioning a support within an interior of a vascular structure such that the support contacts and supports a wall of the vascular structure, and introducing a medical device into the interior of the vascular structure by passing the device through the wall of the vascular structure and through the support.
  • In another embodiment, the invention provides a device and method for stabilizing an area of a patient's heart adjacent a coronary vessel. A device constructed according to this embodiment includes a base configured to be positioned adjacent a coronary vessel of a patient's heart, the base having at least one opening for accessing the coronary vessel. At least one tissue engaging element is coupled to the base so as to be movable with respect to the base, the tissue engaging element having a portion configured to securely engage the wall of a patient's heart in order to stabilize the wall of the heart upon moving the tissue engaging element with respect to the base. An actuator is provided for imparting relative movement to the base and the tissue engaging element in order to stabilize the heart while accessing the coronary vessel through the opening in the base.
  • In yet another embodiment, the invention provides a conduit for placing a coronary vessel of a patient's heart in communication with a heart chamber. The conduit is in the form of a tubular element including first and second portions having different cross-sectional sizes and a bore defining a blood flow path. The cross-section of the first portion of the tubular element is larger than the cross-section of the second portion such that the tubular element is generally funnel-shaped, and the first and second portions of the tubular element are generally aligned so that the bore defines a generally straight blood flow path.
  • In still another embodiment, the invention provides a conduit for communicating a chamber of a patient's heart with a coronary vessel. The conduit is in the form of an expandable stent including first and second portions having different cross-sectional sizes when the stent is expanded. Each of the first and second portions of the stent includes strut members disposed along a first direction when the stent is unexpanded and along a second direction when the stent is expanded, the second direction being transverse to the first direction. The strut members of the first portion are longer than the strut members of the second portion so that the stent is generally funnel-shaped when expanded.
  • In another embodiment, the invention provides a conduit is in the form of an expandable tubular element having first and second portions with different cross-sectional sizes. This tubular element is preferably a coronary stent constructed so that the first and second portions are disposed in an orientation that provides the stent with maximum radial strength when expanded.
  • In a final embodiment, the invention provides a conduit for placing a coronary vessel in communication with a heart chamber, the conduit including a vessel support mechanism configured to contact and support the vessel wall when the conduit is positioned in the heart wall.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • The invention will be better understood from the following detailed description of preferred embodiments thereof, taken in conjunction with the accompanying drawing figures, wherein:
  • FIG. 1 is a schematic view of a patient prepared to undergo a cardiovascular surgical procedure, the patient's heart being exposed via a retractor positioned in a thoracotomy formed in the patient's chest;
  • FIG. 2 is a perspective view of the heart shown in FIG. 1, wherein a portion of the heart wall is broken away for clarity;
  • FIG. 2A is an enlarged view of a portion of FIG. 2;
  • FIGS. 3A-3B are perspective views showing a tissue engaging device constructed according to one embodiment of the invention, the device being shown in collapsed and expanded orientations, respectively;
  • FIGS. 4A-4B are elevation views, in section, illustrating one preferred construction of a tissue engaging device according to the embodiment of FIGS. 3A-3B, wherein the device is shown being used to engage the heart wall shown in FIGS. 2-2A;
  • FIGS. 5A-5B are elevation views, in section, illustrating another preferred construction of a tissue engaging device according to the embodiment of FIGS. 3A-3B, wherein the device is shown being used to engage the heart wall shown in FIGS. 2-2A;
  • FIGS. 6A-6C are elevation views, in section, sequentially illustrating a vessel support device constructed according to another embodiment of the invention being used to support the wall of a vascular structure;
  • FIG. 7 is a perspective view of a vessel support device constructed according to an alternative embodiment of the invention, the device being shown positioned in the interior of a vascular structure;
  • FIGS. 8A-8B are elevation views, in section, sequentially illustrating the device shown in FIG. 7 being used to support a coronary artery of the heart shown in FIGS. 2-2A;
  • FIG. 9 is a perspective view of a vessel support device constructed according to another alternative embodiment of the invention, the device being shown positioned in the interior of a vascular structure;
  • FIGS. 10A-10B are elevation views, in section, sequentially illustrating the device shown in FIG. 9 being used to support a coronary artery of the heart shown in FIGS. 2-2A;
  • FIGS. 11A-11B are plan views of a tissue engaging device constructed according to another embodiment of the invention, wherein the device is shown engaging the wall of the heart shown in FIGS. 2-2A in non-retracting and retracting orientations, respectively;
  • FIGS. 12A-12B are elevation views, in section, taken along lines A-A in FIGS. 1A-1B;
  • FIG. 13 is an elevation view, in section, of an alternative tissue engaging device constructed according to the embodiment shown in FIGS. 12A-12B;
  • FIGS. 14A-14B are elevation views of a tapered balloon forming part of another embodiment of the invention, wherein the balloon is shown in its collapsed and expanded orientations, respectively;
  • FIGS. 15A-15B are elevation views of an expandable conduit mounted on the tapered balloon shown in FIGS. 14A-14B, the conduit being shown in its collapsed and expanded orientations, respectively;
  • FIG. 16 is an elevation view, in section, of a portion of a heart wall and coronary vessel in which the conduit shown in FIG. 15A-15B has been positioned;
  • FIGS. 17A-17B are elevation views showing a conduit constructed according to still another embodiment of the invention, wherein the conduit has a cross-sectional size that varies over its length;
  • FIG. 18 is a perspective view of another embodiment of the invention providing a conduit for placing a coronary vessel in communication with a heart chamber while internally supporting the interior of the vessel;
  • FIGS. 19A-19C are schematic representations of a preferred application for the conduit shown in FIG. 18;
  • FIG. 20 is a perspective view of an alternative embodiment of a conduit for placing a coronary vessel in communication with a heart chamber while internally supporting the interior of the vessel;
  • FIG. 21 is a perspective view of another alternative embodiment of a conduit for placing a coronary vessel in communication with a heart chamber while internally supporting the interior of the vessel; and
  • FIG. 22 is a perspective view of yet another alternative embodiment of a conduit for placing a coronary vessel in communication with a heart chamber while internally supporting the interior of the vessel.
  • DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENT
  • FIG. 1 schematically depicts a patient who has been prepared to undergo a cardiovascular surgical procedure. A thoracotomy T formed in the patient's chest by making an incision between two ribs (not shown) provides access to the thoracic cavity. A retractor, such as the rib retractor R shown in FIG. 1, may be used to spread the ribs and increase access to the heart H and great vessels. The retractor is preferably of a type that in addition to spreading the sides of the incision along a first plane, also raises one side of the incision with respect to the other side to increase the working space around the heart. Any suitable retractor may be used, for example, one of the commercially available rib retractors currently used in minimally invasive cardiac surgery. As shown in FIG. 1, the retractor R provides considerable access to the surfaces of the heart H and great vessels including the aorta A. The left side of the heart as well as the left coronary artery LCA is easily accessible via the thoracotomy T (FIG. 1).
  • FIG. 2 is an anterior view of a heart 10 showing the left ventricle 12, right ventricle 14, right atrium 16, aorta 18, pulmonary trunk 20 and pulmonary veins 22. In FIG. 2 the heart 10 is in diastole, or the relaxed phase of the heart cycle, so the aortic valve 24 is shown closed. The left coronary artery 26, including the circumflex branch 28 and the left anterior descending branch (LAD) 30, is visible in this view, as is the right coronary artery 32. The coronary arteries 26, 28, 30, 32 run along the heart wall 34 and deliver oxygenated blood to the tissue comprising the heart wall (epicardium, myocardium and endocardium) while the coronary veins run alongside the arteries and return blood to the coronary sinus (not shown).
  • A blockage or occlusion 36 is shown in the LAD 30 and results in partial or complete obstruction of the artery lumen 42, a condition often referred to as narrowing of the arteries. This results in inadequate or no blood flow to the heart wall tissue fed by the portion of the LAD 30 that is downstream of the occlusion 36. FIGS. 2-2A show a portion of the heart wall 34 disposed between the left ventricle 12 and the LAD 30, as well as the inner and outer walls 38, 40 of the LAD 30. The devices and methods of the different embodiments of the invention are illustrated and described in connection with their use on the portion of the heart 10 shown in FIG. 2A. It will be understood, however, that such description is for explanatory purposes and exemplifies only one application for the invention.
  • FIGS. 3A-3B illustrate a first embodiment of the invention that provides a device and method for engaging tissue of a coronary vessel or heart wall during a cardiovascular procedure. A preferred device is indicated generally by the reference numeral 100 and includes first and second relatively movable members and a tissue engaging mechanism coupled to the members. In the illustrated embodiment the members comprise first and second coaxial shafts 102, 104 coupled to a tissue engaging mechanism 106. Specifically, the tissue engaging mechanism 106 is coupled to the shafts 102, 104 so that relative movement imparted to the shafts results in the mechanism 106 moving between a collapsed orientation (FIG. 3A) and an expanded, tissue engaging orientation (FIG. 3B).
  • The first shaft 102 has a distal end 108 which is secured to a distal end 110 of the shaft 104. The tissue engaging mechanism 106 is disposed adjacent the distal ends 108, 110 of the shafts 102, 104 and comprises one or more tissue engaging members 112 which move radially outward when the mechanism is in the expanded orientation. Each tissue engaging member 112 has one end 114 fixed to the distal end 108 of shaft 102 at 116, and another end 118 fixed to the shaft 104 at 120. FIG. 3A shows the tissue engaging mechanism 106 in its collapsed orientation with the members 112 generally straight. FIG. 3B shows the tissue engaging mechanism 106 in its expanded orientation in which the members 112 extend outward in a radial direction. The components of the device 100 may be formed of any suitable material.
  • The orientation of the tissue engaging mechanism 106 is controlled by imparting relative movement to the shafts 102, 104. The device 100 is preferably introduced into a coronary vessel or heart wall with the tissue engaging mechanism 106 in the low profile orientation shown in FIG. 3A. The device 100 may have a sharpened tip as shown, or it may have a dilating portion that dilates a previously-formed incision. Once passed through the tissue to a desired position, the tissue engaging mechanism 106 is moved to the expanded orientation shown in FIG. 3B in order to engage tissue. This may be achieved by moving the inner shaft 102 in the direction of the arrows with respect to the outer shaft 104, which moves the ends 114, 118 of the tissue engaging members 112 toward each other to expand the mechanism 106. In the orientation shown in FIG. 3B, the device 100 may be used to perform any of various functions, for example, to support, retract or stabilize tissue during a cardiovascular procedure.
  • FIGS. 4A-4B show one application of the device 100, namely, to engage the tissue of the wall of a patient's heart. As shown in FIG. 4A, the device 100 is inserted through a coronary vessel such as LAD 30 and the heart wall 34 with the tissue engaging mechanism 106 in its collapsed orientation. Upon moving the tissue engaging mechanism 106 out of the heart wall 34 and into a heart chamber such as left ventricle 12, the shafts 102, 104 are moved with respect to each other to expand the tissue engaging mechanism 106 to the position shown in FIG. 4A. The expanded tissue engaging mechanism 106 may then be used to engage and support the heart wall 34 to facilitate carrying out a cardiovascular procedure, for example, placing a conduit (not shown) in the heart wall to place the coronary vessel in communication with the heart chamber, or forming a channel in the heart wall to place the coronary vessel in communication with the heart chamber.
  • FIGS. 5A-5B show another application of the device 100, namely, to engage the tissue of the wall of a coronary vessel. As above, the device 100 is introduced with the tissue engaging mechanism 106 in its collapsed orientation, the device being passed through the heart wall 34 and then the inner wall 38 of the LAD 30. Once the tissue engaging mechanism 106 has moved into the lumen 42 of the LAD 30, the shafts 102, 104 are moved with respect to each other to expand the tissue engaging mechanism 106 to the orientation shown in FIG. 5A. The tissue engaging mechanism 106 may then be used to engage and support the wall 38 of the LAD and the heart wall 34 to facilitate carrying out a cardiovascular procedure. Examples of such procedures include placing a conduit (not shown) in the heart wall to place the coronary vessel in communication with the heart chamber, and forming a channel in the heart wall to place the coronary vessel in communication with the heart chamber.
  • As shown in FIGS. 3A-3B, the device 100 may have a second tissue engaging mechanism 106A so that a body of tissue may be sandwiched between the two mechanisms 106, 106A for added stability.
  • FIGS. 6A-6C depict another embodiment of the invention that provides a device and method for supporting a wall of a vascular structure in order to access the lumen of the vascular structure. One device constructed according to this embodiment is designated generally by the reference numeral 130 and includes an elongated support member 132 and an introducer 134. The introducer has a bore 136 that is configured to receive the support member 132, as shown in FIG. 6A and preferably has a small diameter in order to minimize the size of the opening in the vascular structure, which in the illustrated embodiment is a coronary vessel and, in particular, LAD 30.
  • The elongated support member 132 is preferably constructed so as to expand when in an unbiased orientation, i.e., when it is not constrained by the introducer 134. In the preferred embodiment, the support member 132 is constructed to assume a coiled shape when in the unbiased orientation, for example, the helical configuration shown in FIG. 6B. When disposed in the introducer 134, however, the support member 132 is in a biased orientation and assumes a generally straight shape within the bore 136 of the introducer.
  • An exemplary application for the device 130 will be explained with reference to FIGS. 6A-6C. Initially, as shown in FIG. 6A, an end 138 of the introducer 134 is positioned against the exterior of the wall 40 of the LAD with the elongated support member 132 disposed within the introducer 134. Alternatively, as shown in phantom in FIG. 6A, the end 138 of the introducer 134 may be passed through the wall 40 into the lumen 42 of the LAD 30. If used in this manner, the support member 132 does not need to pierce the tissue of the vascular structure; if used as shown in solid lines in FIG. 6A, an end 140 of the support member 132 is preferably sharpened to pierce through the wall of the vascular structure.
  • The elongated support member 132 is fed through the introducer 134 into the lumen 42 of the LAD 30. The support member 132 forms a coil 142 as it exits the introducer 134, as shown in FIG. 6B. The support member is constructed so that the coil 142 has a size that contacts and distends slightly the LAD 30, thereby providing support to the LAD to allow precise entry into the lumen 42 of the LAD. A medical device may then be inserted through the wall of the vascular structure and the support member. For example, FIG. 6C shows a medical device 144 inserted through the wall 40 of the LAD 30 and through the coil 142. The device 144 is then removed upon completing the procedure; the elongated support member 132 may then be removed from the LAD 30 by retracting the member back into the bore 136 of the introducer 134.
  • The elongated support member 132 may be formed of any suitable material having sufficient memory to assume an expanded configuration when unbiased, such as spring wire or nitinol. As an example, the support member 132 could be formed of a length of nitinol wire having an approximate diameter of 0.007 inch that has been wrapped on a suitable mandrel (not shown), such as a stainless steel rod having an approximate diameter of 0.060 inch. The mandrel and wire are then heated to set the shape in the wire which, per se, is known in the art. The mandrel may have two apertures that receive the ends of the nitinol wire and a relief section that causes the end 140 of the support member to roll inward toward the interior of the coil 142, which minimizes the risk of the end 140 damaging tissue.
  • It will be recognized that the device 130 may be used to support a vascular structure independently of carrying out a medical procedure. As an example, the device 130 could be used to introduce the support member 132 into a coronary artery in order to stent the artery, the coil 142 remaining in place in the same manner as a conventional coronary stent. In this embodiment, it may be desirable to form the other end 146 of the support member 132 so that it too moves toward the interior of the coil 142 upon exiting the introducer 134 to avoid tissue damage.
  • FIGS. 7 and 8A-8B depict an alternative embodiment of a device and method for supporting a wall of a vascular structure in order to access the lumen of the vascular structure. The device is indicated generally by the reference numeral 160 and is configured to be placed in a collapsed orientation for introduction into a vascular structure and then expanded to contact and support the wall of the structure. The device 160 comprises a support structure 162 removably retained in an introducer 164. The illustrated support structure 162 comprises a plurality of struts 166 that form a basket-like member when moved out of the introducer 164. For example, the struts 166 may be in the form of resilient wires that move away from each other as the support structure 162 exits the introducer 164, the wires extending between proximal and distal portions 168, 170 of the support structure. The introducer 164 may be a sheath or sleeve sized and configured to at least partially surround the support structure 162 and hold the struts 166 together. The respective components may be formed of suitable materials, such as spring wire and a polymer sleeve.
  • FIG. 7 shows one preferred use of the device 160 wherein the device is inserted through an opening in a vascular structure, such as incision 44 in LAD 30. It will be noted, though, that the device may be passed through a peripheral vessel to a desired location within a vascular structure, and then expanded within the vascular structure by moving the support structure out of the introducer. As shown in FIG. 8A, the device is passed through the incision 44 and into the lumen 42 of the LAD 30. The introducer 164 is then retracted over the proximal portion 168 of the support structure which results in the struts 166 moving away from each other to contact and support the wall of LAD 30. As explained above with respect to the previous embodiment, various medical devices may then be introduced through the wall of the vascular structure and through the support structure 162. Upon completion of the procedure, the introducer 164 is slid back over the struts 166 to collapse the support structure 162, which allows the device 160 to be removed through the incision 44.
  • FIGS. 9 and 10A-10B illustrate another alternative embodiment of a device and method for supporting a wall of a vascular structure in order to access the lumen of the vascular structure. The device has a construction somewhat similar to the device 160 in FIGS. 7 and 8A-8B. The device is indicated generally by the reference numeral 180 in FIG. 9 and is configured to be placed in a collapsed orientation for introduction into a vascular structure and then expanded to contact and support the wall of the structure. The device 180 comprises a support structure 182 removably retained in an introducer 184. The illustrated support structure 182 includes a plurality of struts 186 which may be in the form of resilient wires that move away from each other as the support structure exits the introducer 184. The struts 186 may be joined at their proximal ends 188 and preferably have distal ends 190 with a non-traumatic configuration to prevent tissue damage. As in the previous embodiment, the introducer 164 may be a sheath or sleeve sized and configured to at least partially surround the support structure 162 to hold the struts 186 together. The materials used in the embodiment of FIG. 7 may be used in this embodiment.
  • As shown in FIG. 10A, the device 180 is passed through the incision 44 and into the lumen 42 of the LAD 30, and the introducer 184 is then retracted to allow the struts 186 to move away from each other. This results in the support structure 182 assuming the expanded orientation shown in Fig. 10B wherein the struts 186 contact and support the wall of LAD 30. As with the previous embodiments, various medical devices may then be introduced through the wall of the vascular structure and through the support structure 162.
  • It will be appreciated that the vascular support devices and methods illustrated in the drawings are only preferred embodiments of the invention. This aspect of the invention encompasses supporting the wall of a vascular structure in order to allow precise entry into the lumen, which may be relatively difficult if the wall of the vascular structure is collapsed. Accordingly, many variations of the disclosed devices and methods will be apparent to those skilled in the art. For example, an alternative design utilizes an expandable support that may be in the form of a stent having one or more openings to allow passage of medical devices into the lumen of the vascular structure. The stent could have any desired coverage area with openings provided between adjacent stent elements or formed by removing portions of the stent elements.
  • Another alternative design comprises a device in the form of a member configured to rest on the exterior of the vascular structure to provide access into the lumen of the structure. The device may have a distal portion shaped somewhat complementarily to the vascular structure to closely engage same. For example, the distal portion could include a concave recess that receives the vascular structure when the device is rested on surrounding tissue. The device preferably has a bore that opens into the recess so that a medical device inserted into the bore passes through the wall of the vascular structure.
  • Additionally, while the vessel support devices are shown introduced into the vessel through the wall close to or at the area of the vessel that is supported. The support devices could be positioned in an alternative manner, for example, by passing the device through the artery lumen from a location downstream of the area that is supported.
  • FIGS. 11A-11B and 12A-12B show another embodiment of the invention that provides devices and methods for stabilizing an area of a patient's heart adjacent a coronary vessel. The illustrated device is indicated generally by the reference numeral 200 and comprises a base 202 configured to be positioned adjacent a coronary vessel of a patient's heart. The base 202 has at least one opening 204 which provides access to the coronary vessel, which, in the illustrated embodiment, is the LAD 30. The device 200 also includes at least one, and preferably a plurality, of tissue engaging elements 206 coupled to the base 202 so as to be movable with respect thereto. Each tissue engaging element 206 has an end 208 configured to securely engage the tissue of a patient's heart in order to stabilize the heart, and an end 210 coupled to the base 202. Each end 210 is pivotally attached to the base 202 by a pivot pin 212.
  • The base 202 has a plurality of recesses 214 each of which mounts an end 210 of a tissue engaging element 206. Each of the recesses 214 has a cam surface 216 that engages the end 210 of a tissue engaging element 206 upon actuating the device in order to retract the cardiac tissue and stabilize the heart. To that end, the device 200 has an actuator to drive the tissue engaging elements 206 and retract tissue. The actuator may comprise rotating the base 202 so as to drive the cam surfaces 216 of recesses 214 against the ends 210 of the tissue engaging elements 206. FIG. 11A shows the device 200 before actuation; FIG. 11B shows the device after the base 202 has been rotated. Each tissue engaging element 206 is preferably biased to the position of FIGS. 11 A and 12A by suitable means, such as tension springs extending between the base 202 and the tissue engaging elements 206. The components of the device 200 may be made from any suitable materials; for example, the base may comprise a polymer while the elements 206 are metal.
  • FIGS. 11A-11B and 12A-12B show one possible application for the device 200, retracting the wall of a heart adjacent a coronary vessel to stabilize vessel. The device 200 is positioned on the heart wall 34 so that the opening 204 overlies the LAD 30. The ends 208 of the tissue engaging elements 206 are engaged with the tissue of the heart wall 34 by any suitable means. As shown in FIGS. 12A-12B, the ends 208 may simply have sharp tips which are passed into the tissue to engage the elements with the heart wall.
  • Alternatively, as shown in FIG. 13, the ends 208 of the tissue engaging elements 206 may have a mechanism for more securely engaging the tissue, such as expandable members 218. The expandable members 218 may be constructed as described above with respect to the embodiment of FIGS. 3A-3B, thereby allowing the ends 208 to be collapsed, for passage through the heart wall and then expanded once through the wall in order to positively secure the device 200 to the tissue. The members 218 may be expanded by moving one shaft relative to another as described above.
  • Once the ends of the tissue engaging elements have been secured to the tissue, as shown in FIGS. 11A and 12A, the base 202 is rotated as described above,. which drives the tissue engaging elements relative to the base and the tissue. This action tensions the tissue of the heart wall 34 to retract the wall and stabilize the heart in the area of the coronary vessel, as shown in FIGS. 11B and 12B. As a result, the coronary vessel, which is the LAD 30 in the Figures, is stabilized so that subsequent procedures may be carried out on a relatively stable site. As an example, the device 200 may be used to stabilize the heart while passing a conduit delivery device through the vessel and the heart wall in order to place the vessel in communication with a heart chamber.
  • According to another embodiment of the invention, a conduit is provided for placing a coronary vessel of a patient's heart in communication with a heart chamber. The conduit comprises a tubular element including first and second portions having different cross-sectional sizes, and a bore defining a blood flow path. The cross-section of the first portion of the tubular element is larger than the cross-section of the second portion of the tubular element. In one preferred embodiment the different cross-sectional configurations are selected to produce a tubular element that is generally funnel-shaped.
  • According to one aspect of this embodiment, the first and second portions of the tubular element are generally aligned and the bore defines a generally straight blood flow path. According to another aspect of this embodiment, the tubular element is an expandable stent including a bore defining a blood flow path and first and second portions, the first and second portions having different cross-sectional sizes when the stent is expanded. The first and second portions of the stent are preferably constructed to provide the stent with maximum radial strength when expanded.
  • FIGS. 14A-14B and 15A-15B show one preferred system for placing a funnel-shaped conduit in a patient's heart wall to communicate a coronary vessel with a heart chamber. The system includes a balloon 220 and a conduit 222. The balloon 220 is generally straight over its length when unexpanded (FIG. 14A); however, when expanded the balloon 220 assumes a tapered orientation with a large end 224 and a small end 226 (FIG. 14B). The conduit 222 is also preferably straight over its length when supported by the balloon 220 in a collapsed orientation (FIG. 15A) and funnel shaped when expanded by the balloon (FIG. 15B). It should be understood that a tapered balloon is not necessary to expand a tapered or funnel-shaped stent. For example, a straight balloon could be used to expand a stent constructed to assume a funnel-shaped configuration, with the inflated size of the balloon preferably being sufficient to fully expand the large end of the stent.
  • FIG. 16 depicts an exemplary application of the conduit 202 shown in FIGS. 15A-15B. The conduit 202 is shown positioned in a heart wall 34 with a large diameter end 228 located in a heart chamber such as the left ventricle 12 and a small diameter end 230 located in a coronary vessel such as LAD 30. It will be appreciated that the shape, size and orientation of the conduit 202 in the heart wall and coronary vessel may be varied from that shown in FIG. 16. For example, the taper of the conduit wall may be non-continuous or more gradual or severe than that shown in the Figures, or either end of the conduit may be flush or within the heart wall. Also, the conduit may be a rigid or expandable tubular element.
  • FIGS. 17A-17B show one preferred funnel-shaped stent 240 that includes a plurality of stent elements in the form of struts 242 that move relative to each other as the stent moves to its expanded orientation. The struts 242 are joined at nodes 244 which move along with the struts as the stent 240 moves to its expanded orientation. A plurality of open areas are defined between the struts 242 through which blood may flow.
  • FIG. 17A shows the stent 240 in its collapsed orientation. As shown, the stent 240 comprises a first portion 246, a second portion 248 and a third portion 250. These three portions 246, 248, 250 are designed so that upon expansion they have different diameters or cross-sectional dimensions. This may be achieved by using different length struts 242 for the respective portions 246, 248, 250. The relative dimensions of the struts (and thus the relative size of the expanded portions formed by the struts) may be varied to achieve different sizes and shapes. Referring to FIG. 17B, the illustrated stent 240 is constructed so that the first portion 246 expands to the smallest diameter while the third portion 250 expands to the largest diameter. The second portion 248 expands to a middle diameter that tapers between the portions 246, 250. The struts 242 of the stent 240 preferably assume a maximum load supporting position when fully expanded.
  • The stent 240 may be used in various applications, including forming a blood flow path between a coronary vessel and a heart chamber. The stent 240 (or another conduit constructed according to this embodiment of the invention) may be used as a coronary stent to improve blood flow through a coronary artery. In this application, the stent 240 would be introduced into a peripheral vessel and guided to the desired artery by conventional means.
  • FIGS. 18 and 19A-19C show another embodiment of the invention providing a conduit for placing a coronary vessel in communication with a heart chamber, the conduit including a mechanism for internally supporting the interior of the vessel. FIG. 18 shows a conduit 260 in the form of a rigid, tubular element having a first end 262 and a second end 264. The conduit 260 has a bore 266 passing therethrough that defines a blood flow path. A mechanism 268 is provided to support the wall of a coronary vessel with which the conduit 260 communicates. The mechanism 268 includes a pair of support arms 270 preferably in the form of flexible members made from any suitable material, such as stainless steel, nitinol, polymers, etc. A pair of support arms 270 is shown; however, any desired number of arms may be used. Each support arm 270 is secured to the conduit 260 at 272, for example, by welding, brazing or adhesive. Alternatively, the support arms 270 may be integrally formed as part of the conduit 260. The support arms 270 are provided with vessel supporting portions 274 which may be formed by rounded lengths of wire 276, as shown.
  • Referring to FIG. 19A, which schematically illustrates one preferred application of the conduit 260, the support arms 270 may be folded against the wall of the conduit 260 so that the conduit assumes a relatively low profile position. The conduit 260 is then passed through an opening in the wall of a coronary vessel such as the LAD 30 (FIG. 19A). The support arms 270 may be constrained against the conduit 260 manually, with an instrument, or with a removable sheath or cover. The conduit 260 is delivered into the lumen 42 of the LAD and the heart wall 34 an amount sufficient to place all (or substantially all) of the support arms 270 inside the outer wall 40 of LAD 30 (FIG. 19B). At this point the support arms 270 spring out to the position shown in FIG. 18, which results in the vessel supporting portions 274 of the arms contacting the walls of the LAD 30 (FIG. 19C). The conduit is preferably configured so that when the support arms are in this position the conduit end 262 extends into the left ventricle 12 while the conduit end 264 extends into the LAD 30.
  • FIG. 20 shows an another embodiment of a conduit with a vessel supporting mechanism. The conduit is designated 280 and preferably is a rigid tubular element as in the previous embodiment. The conduit 280 has a mechanism 282 that supports the wall of a coronary vessel in which the conduit is placed. The support mechanism 282 includes three support arms 284 in the form of hoops made from any suitable material, as discussed above. The support arms 284 are also preferably flexible and secured to the conduit 280 by welding, brazing or adhesive. The support arms 284 have vessel supporting portions 286 that contact and may slightly distend the vessel wall. While three arms 284 are shown, any desired number may of course be used.
  • FIG. 21 shows still another embodiment of a conduit with a vessel supporting mechanism. The conduit is designated 290 and preferably is a rigid tubular element as in the previous embodiments. The conduit 290 is provided with a mechanism 292 for supporting the wall of a coronary vessel. The vessel support mechanism 292 includes a first pair of support arms 294 and a second pair of support arms 296 in the form of tabs made from any suitable material, as discussed above. The support arms 294 extend generally along the longitudinal axis of the conduit 290 and are adapted to contact the outer wall of a coronary vessel, while the support arms 296 extend radially from the conduit 290 and are adapted to contact the inner wall of the vessel. The support arms 294, 296 are preferably integrally formed with the conduit 290 and are flexible to assume a low profile position. It will be noted that the support arms 294, 296 could be separate members secured to the conduit by suitable means such as welding, brazing or adhesive. Also, although three arms 284 are shown, any desired number may be used.
  • FIG. 22 shows yet another embodiment of a conduit with a vessel supporting mechanism. The conduit is designated 300 and, instead of being a rigid tubular element as in the previous embodiments, is an expandable tubular element, for example, a coronary stent. The conduit 300 has stent elements in the form of struts 302 joined at nodes 304. The conduit 300 may be formed substantially in the same manner as the stent 240 in FIGS. 17A-17B. The conduit 300, however, is provided with a mechanism 306 for supporting the wall of a coronary vessel. The vessel support mechanism 306 in this embodiment includes a pair of extensions 308 that are preferably formed as an integral part of the stent struts 302. The extensions 308 extend generally along the longitudinal axis of the conduit 290 so as to contact the outer wall of a coronary vessel, thereby supporting the wall in the manner discussed above. The ends 310 of the extensions 308 may be unattached, as shown, or attached.
  • The conduit 300 may be mounted on a balloon or other expandable member (not shown) in a collapsed orientation for introduction into the coronary vessel and the heart wall. The extensions 308 can be loaded on the balloon with the remaining portion of the conduit 300. Once properly positioned in the heart wall, the balloon is inflated to expand the conduit 300 to the orientation shown in FIG. 22. It should be recognized that this embodiment of the invention may be carried out using any expandable conduit, the particular stent shown in FIG. 22 representing only one possible construction. Also, the extensions 308 could be separate members secured to the conduit 300 by suitable means such as welding, brazing or adhesive. Finally, although two extensions 308 are provided on the illustrated conduit, any number of extensions may be used.
  • It should be noted that, as used herein, the term conduit refers to any structure that is capable of conveying fluid from one point to another, for example, a tubular element with two or more open ends. In view of the fact that various characteristics of the conduit, for example, size, shape and surface configuration, may vary depending on the application, it will be recognized that the conduits in the illustrated embodiments are merely exemplary. For instance, the conduit could be a rigid, flexible or expandable tubular element formed of metal, polymers or composite materials having solid or perforated walls. The conduit could be straight over its length with the ends aligned or the ends could be offset, the exterior surface of the conduit may be treated to enhance fixation of the conduit in the heart wall, and the conduit may or may not include a valve or other flow controlling mechanism. Further, a conduit constructed according to the invention may be used to deliver various pharmaceutical substances, such as angiogenic growth factors or other substances that aid in the perfusion of surrounding myocardial tissue.
  • It will be understood that the LAD 30 illustrated in the Figures is but one example of a possible vessel which may be placed in communication with a heart chamber.
  • Similarly, in the preferred embodiments the LAD 30 is placed in communication with a heart chamber that contains blood, which, in the illustrated embodiments, is the left ventricle 12. It will be understood, however, that the invention may be used to place a conduit in communication with any source of blood (arterial or venous), for example, another heart chamber such as the left atrium, or the aorta, pulmonary veins, etc.
  • It also will be appreciated that the various devices of the invention incorporated in the illustrated embodiments may be used together or separately, and the methods may be modified, carried out by combining particular steps, or varying the sequence of steps. Further, it will be understood that the embodiments may be used in various types of procedures, for example, the surgical approach depicted in FIG. 1, an open surgical procedure including a median sternotomy, or a minimally invasive procedure utilizing one or more relatively small access openings or ports. Endoscopes or thoracoscopes may be used for visualization if the procedure is truly minimally invasive. Additionally, rather than forming one or more incisions in the patient's chest wall, an endovascular approach may be used to guide various inventive devices to the heart through the patient's vascular system to the heart, for example, by introducing the devices into a peripheral vessel such as the femoral artery. Similarly, the different embodiments may be used in beating heart procedures, stopped-heart procedures utilizing cardiopulmonary bypass (CPB), or procedures during which the heart is intermittently stopped and started.
  • The preferred embodiments of the invention are described above in detail for the purpose of setting forth a complete disclosure and for sake of explanation and clarity. It will be readily understood that the scope of the invention defined by the appended claims will encompass numerous changes and modifications.

Claims (46)

1. A device for engaging tissue of a coronary vessel or heart wall during a cardiovascular procedure, the device comprising:
a first member;
a second member coupled to the first member so as to permit relative movement of the first and second members; and
a tissue engaging mechanism coupled to the first and second members so as to be movable between a first position and a second, actuated position, the tissue engaging mechanism including at least one tissue engaging member configured to engage body tissue when the tissue engaging mechanism is in the second actuated position;
wherein relative movement of the fist and second members moves the tissue engaging mechanism between the collapsed and expanded orientations to selectively place the tissue engaging member in engagement with body tissue.
2. The device of claim 1, wherein the first and second members are first and second coaxial shafts with the tissue engaging mechanism extending therebetween, and relative axial movement of the first and second shafts moves the tissue engaging mechanism between a collapsed orientation and an expanded orientation.
3. The device of claim 2, wherein each of the first and second shafts has a proximal end and a distal end, and the tissue engaging mechanism is disposed adjacent the distal ends of the shafts.
4. The device of claim 3, wherein at least one of the first and second shafts has a portion configured to be passed through and dilate an opening in tissue, wherein the tissue engaging mechanism may be positioned adjacent tissue and then expanded to engage the tissue.
5. The device of claim 1, further comprising an actuator coupled to the first and second members for imparting relative movement thereto in order to move the tissue engaging mechanism between the collapsed and expanded orientations.
6. The device of claim 5, wherein the actuator comprises a handle coupled to one of the first and second members for moving the one member relative to the other member.
7. The device of claim 1, wherein the tissue engaging mechanism includes a non-inflatable structure that is moved between the collapsed and expanded orientations.
8. The device of claim 1, wherein the tissue engaging mechanism includes a plurality of tissue engaging members each of which has opposite ends coupled, respectively, to the first and second members, wherein relative movement of the first and second members imparts relative movement to the ends of the tissue engaging members to move the tissue engaging mechanism between the collapsed and expanded orientations.
9. The device of claim 1, wherein the tissue engaging mechanism includes a balloon that is inflated by pressurized fluid to engage the tissue.
10. The device of claim 1, wherein the tissue engaging mechanism includes an expandable mesh that is moved between the collapsed and expanded orientations in response to relative movement of the first and second members.
11. The device of claim 1, wherein first and second tissue engaging mechanisms are coupled to the first and second members so that each mechanism is movable between a collapsed orientation and an expanded orientation, the first and second tissue engaging mechanisms being spaced from each other to permit body tissue to be captured therebetween with the first and second tissue engaging mechanisms engaging opposite surfaces of the body tissue.
12. A method for supporting heart tissue during a medical procedure, the method comprising steps of:
providing a tissue support device having a tissue engaging mechanism configured to assume an expanded, tissue supporting orientation;
positioning the tissue support device through the wall of a patient's heart and locating the tissue engaging mechanism adjacent heart tissue; and
placing the tissue engaging mechanism in the expanded, tissue supporting orientation in engagement with the heart tissue.
13. The method of claim 12, further comprising positioning a conduit in the wall of the heart to place a coronary vessel in communication with a heart chamber.
14. A device for supporting a wall of a vascular structure, the device comprising:
a support structure adapted to be removably positioned in the lumen of a vascular structure, the support structure comprising a plurality of support elements coupled together so as to be movable relative to each other, wherein moving the support elements relative to each other moves the support structure from a collapsed orientation to an expanded orientation in order to support a wall of a vascular structure; and
wherein the support elements are sized and configured for positioning in the interior of the vascular structure such that when the support structure is in the expanded orientation the support elements engage the wall of the vascular structure to prevent the wall from collapsing.
15. The device of claim 14, wherein the support elements comprise a plurality of flexible struts each of which has a free end, wherein the free ends of the struts are moved apart to place the support structure in the expanded orientation.
16. The device of claim 15, further comprising a sheath coupled to the flexible struts so that movement of the sheath relative to the struts moves the free ends of the struts apart to place the support structure in the expanded orientation.
17. The device of claim 14, wherein the support elements comprise a plurality of flexible struts each of which has first and second ends and a central portion between the ends, wherein the first ends of the struts are fixed to each other and the second ends of the struts are fixed to each other such that the central portions of the struts move away from each other as the support structure moves to the expanded orientation.
18. The device of claim 16, further comprising a sheath slidable over the flexible struts, wherein the sheath is placed over at least a portion of the struts to move the support structure to the collapsed orientation and is removed from the said portion of the struts to move the support structure in the expanded orientation.
19. A device for supporting a vascular structure, the device comprising:
an introducer having a hollow interior;
an elongated support member configured to be generally coiled when in an unbiased orientation and generally straight when in a biased orientation;
wherein the interior of the introducer is sized and configured to receive the elongated support member and hold the support member in the generally straight, biased orientation; and
wherein the elongated support member is moved from the straight, biased orientation within the interior of the introducer to the coiled, unbiased orientation upon entering the interior of the vascular structure to support the vascular structure.
20. The device of claim 19, wherein the elongated support member is a superelastic wire that is generally straight when in the biased orientation and generally helical when in the unbiased orientation.
21. The device of claim 20, wherein an end of the elongated support member is sharpened for forming an opening in the wall of the vascular structure to pass the support member into the interior of the vascular structure.
22. The device of claim 19, wherein the elongated support member is adapted to be removed from the vascular structure via the opening through which the support member is passed into the vascular structure.
23. A method for internally supporting a wall of a vascular structure, the method comprising steps of:
(a) positioning a support within an interior of a vascular structure such that the support contacts and supports a wall of the vascular structure; and
(b) introducing a medical device into the interior of the vascular structure by passing the device through the wall of the vascular structure and through the support.
24. The method of claim 23, wherein the support is an elongated member configured in a generally straight orientation prior to being positioned in the interior of the vascular structure and assumes a generally coiled orientation once positioned in the interior of the vascular structure, the medical device being introduced between coils of the support into the vascular structure.
25. The method of claim 23, wherein the support is movable between collapsed and expanded orientations, and step (a) is carried out by introducing the support into the vascular structure in said collapsed orientation and then moving the support to said expanded orientation.
26. The method of claim 23, wherein the support comprises a sleeve having at least one opening formed therein through which the medical device is introduced.
27. The method of claim 23, wherein the vascular structure is a coronary artery and the medical device is a conduit delivery device that is passed through the coronary artery to position a conduit in the wall of the heart to communicate the coronary artery with a heart chamber.
28. The method of claim 23, further comprising the step of removing the medical device and the support from the vascular structure.
29. A method for supporting a wall of a vascular structure at an area adjacent an incision in the wall of the vascular structure, the method comprising steps of:
inserting a support through the incision in the wall of the vascular structure while the support is in a low profile orientation;
positioning at least a portion of the support within the interior of the vascular structure; and
moving the support from the low profile orientation into an expanded orientation so as to contact and support the wall of the vascular structure.
30. The method of claim 29, further comprising introducing a medical device into the interior of the vascular structure by passing the device through the support.
31. The method of claim 30, wherein the vascular structure is a coronary artery and the medical device is a conduit delivery device that is passed through the coronary artery to position a conduit in the wall of the heart to communicate the coronary artery with a heart chamber.
32. A device for stabilizing an area of a patient's heart adjacent a coronary vessel, the device comprising:
a base configured to be positioned adjacent a coronary vessel of a patient's heart, the base having at least one opening for accessing the coronary vessel;
at least one tissue engaging element coupled to the base so as to be movable with respect to the base, the tissue engaging element having a portion configured to securely engage the wall of a patient's heart in order to stabilize the wall of the heart upon moving the tissue engaging element with respect to the base; and
an actuator for imparting relative movement to the base and the tissue engaging element in order to stabilize the heart while accessing the coronary vessel through the opening in the base.
33. The device of claim 32, wherein the base has a single opening for accessing the coronary vessel and a plurality of tissue engaging elements are coupled to the base.
34. The device of claim 33, wherein the tissue engaging elements comprise legs each of which has one end pivotally attached to the base and another end provided with a member configured to at least partially penetrate the wall of the heart.
35. The device of claim 34, wherein the base has a plurality of recesses each of which pivotally mounts the one end of one of the legs, each recess having a cam surface that moves the leg with respect to the base when the base is rotated.
36. The device of claim 32, wherein the tissue engaging elements include a sharpened end configured to partially penetrate the wall of the heart.
37. The device of claim 36, wherein each tissue engaging element has an end provided with an expandable member, the expandable member configured to be passed through the wall of the heart to a location adjacent a surface of the wall opposite the coronary vessel and then expanded to engage said surface of the wall.
38. A conduit for placing a coronary vessel of a patient's heart in communication with a heart chamber, the conduit comprising:
a tubular element including first and second portions having different cross-sectional sizes, the tubular element having a bore defining a blood flow path;
wherein the cross-section of the first portion of the tubular element is larger than the cross-section of the second portion of the tubular element such that the tubular element is generally funnel-shaped; and
wherein the first and second portions of the tubular element are generally aligned and the bore defines a generally straight blood flow path.
39. A conduit for communicating a chamber of a patient's heart with a coronary vessel, the conduit comprising:
an expandable stent including first and second ends and a length defined between the ends, the length of the stent including first and second portions having different cross-sectional sizes when the stent is expanded;
wherein each of the first and second portions of the stent includes strut members disposed along a first direction when the stent is unexpanded and along a second direction when the stent is expanded, the second direction being transverse to the first direction; and
wherein the strut members of the first portion are longer than the strut members of the second portion and the stent is generally funnel-shaped when expanded.
40. A device for use in a coronary vessel of a patient's heart, the device comprising:
an expandable stent including a bore defining a blood flow path and first and second portions, the first and second portions having different cross-sectional sizes when the stent is expanded;
wherein the first portion has a larger cross-sectional dimension than the second portion when the stent is expanded such that the stent is generally funnel-shaped when expanded; and
wherein the first and second portions of the stent are constructed to provide the stent with maximum radial strength when expanded.
41. The device of claim 40, wherein the stent is configured to be positioned and retained in a heart wall to place a coronary vessel in communication with a heart chamber.
42. The device of claim 40, wherein the stent has a plurality of openings along the length of the stent through which blood may flow.
43. (canceled)
44. A conduit for placing a coronary vessel of a patient's heart in communication with a heart chamber, the conduit comprising:
a tubular element configured to positioned in the wall of a patient's heart, the tubular element including first and second ends and a bore defining a blood flow path; and
a vessel supporting mechanism carried by the tubular element, the vessel supporting mechanism being positioned on the conduit so as to contact and support the wall of a coronary vessel when the conduit is positioned in the heart wall.
45. The conduit of claim 44, wherein the tubular element is a rigid, solid walled structure.
46. The conduit of claim 44, wherein the tubular element is an expandable stent including a plurality of struts, and the vessel supporting mechanism comprises some of the struts.
US11/594,464 1998-02-13 2006-11-08 Devices and methods for use in performing transmyocardial coronary bypass Abandoned US20070055344A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US11/594,464 US20070055344A1 (en) 1998-02-13 2006-11-08 Devices and methods for use in performing transmyocardial coronary bypass

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US2349298A 1998-02-13 1998-02-13
US10/011,630 US7137962B2 (en) 1998-02-13 2001-10-22 Devices and methods for use in performing transmyocardial coronary bypass
US11/594,464 US20070055344A1 (en) 1998-02-13 2006-11-08 Devices and methods for use in performing transmyocardial coronary bypass

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US10/011,630 Division US7137962B2 (en) 1998-02-13 2001-10-22 Devices and methods for use in performing transmyocardial coronary bypass

Publications (1)

Publication Number Publication Date
US20070055344A1 true US20070055344A1 (en) 2007-03-08

Family

ID=21815415

Family Applications (3)

Application Number Title Priority Date Filing Date
US09/833,921 Abandoned US20010025643A1 (en) 1998-02-13 2001-04-11 Methods and devices providing transmyocardial blood flow to the arterial vascular system of the heart
US10/011,630 Expired - Fee Related US7137962B2 (en) 1998-02-13 2001-10-22 Devices and methods for use in performing transmyocardial coronary bypass
US11/594,464 Abandoned US20070055344A1 (en) 1998-02-13 2006-11-08 Devices and methods for use in performing transmyocardial coronary bypass

Family Applications Before (2)

Application Number Title Priority Date Filing Date
US09/833,921 Abandoned US20010025643A1 (en) 1998-02-13 2001-04-11 Methods and devices providing transmyocardial blood flow to the arterial vascular system of the heart
US10/011,630 Expired - Fee Related US7137962B2 (en) 1998-02-13 2001-10-22 Devices and methods for use in performing transmyocardial coronary bypass

Country Status (6)

Country Link
US (3) US20010025643A1 (en)
EP (1) EP1054641A1 (en)
JP (1) JP2002502663A (en)
AU (1) AU755190B2 (en)
CA (1) CA2320956A1 (en)
WO (1) WO1999040868A1 (en)

Cited By (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040097988A1 (en) * 1999-01-15 2004-05-20 Ventrica, Inc. Methods and devices for placing a conduit in fluid communication with a target vessel
US20040168691A1 (en) * 1998-02-13 2004-09-02 Sharkawy A. Adam Conduits for use in placing a target vessel in fluid communication with source of blood
US20050043781A1 (en) * 1998-02-13 2005-02-24 Mark Foley Methods and devices providing transmyocardial blood flow to the arterial vascular system of the heart
US20070233225A1 (en) * 1998-02-13 2007-10-04 Rapacki Alan R Delivering a conduit into a heart wall to place a coronary vessel in communication with a heart chamber and removing tissue from the vessel or heart wall to facilitate such communication
US20070290497A1 (en) * 2006-06-15 2007-12-20 Arendt Albert L Children's ride-on vehicles with reconfigured bodies and methods for forming the same
US20080018016A1 (en) * 1999-09-10 2008-01-24 Rapacki Alan R Manufacturing conduits for use in placing a target vessel in fluid communication with a source of blood
US20080171101A1 (en) * 1999-09-10 2008-07-17 Rapacki Alan R Manufacturing conduits for use in placing a target vessel in fluid communication with a source of blood
US20080194939A1 (en) * 2004-09-08 2008-08-14 Advotek Medical Devices Ltd. Minimally Invasive Surgical Appartus and Methods
US20100268316A1 (en) * 2004-08-27 2010-10-21 Rox Medical, Inc. Device and method for establishing an artificial arterio-venous fistula
US9545263B2 (en) 2014-06-19 2017-01-17 Limflow Gmbh Devices and methods for treating lower extremity vasculature
US10543308B2 (en) 2017-04-10 2020-01-28 Limflow Gmbh Methods for routing a guidewire from a first vessel and through a second vessel in lower extremity vasculature
US11116943B2 (en) 2018-10-09 2021-09-14 Limflow Gmbh Methods for accessing pedal veins
US11207457B2 (en) * 2004-08-27 2021-12-28 Edwards Lifesciences Corporation Device and method for establishing an artificial arterio-venous fistula
US11612397B2 (en) 2019-11-01 2023-03-28 Limflow Gmbh Devices and methods for increasing blood perfusion to a distal extremity
WO2023220119A1 (en) * 2022-05-10 2023-11-16 Abiomed, Inc. Distal limb perfusion cannula stent & stent cannula cover

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999040868A1 (en) 1998-02-13 1999-08-19 Ventrica, Inc. Methods and devices providing transmyocardial blood flow to the arterial vascular system of the heart
EP1112043B1 (en) * 1998-09-10 2006-04-05 Percardia, Inc. Tmr shunt
US6254564B1 (en) 1998-09-10 2001-07-03 Percardia, Inc. Left ventricular conduit with blood vessel graft
US6290728B1 (en) 1998-09-10 2001-09-18 Percardia, Inc. Designs for left ventricular conduit
US6261304B1 (en) 1998-09-10 2001-07-17 Percardia, Inc. Delivery methods for left ventricular conduit
US6641610B2 (en) 1998-09-10 2003-11-04 Percardia, Inc. Valve designs for left ventricular conduits
US6432126B1 (en) * 1998-09-30 2002-08-13 C.R. Bard, Inc. Flexible vascular inducing implants
US6458092B1 (en) * 1998-09-30 2002-10-01 C. R. Bard, Inc. Vascular inducing implants
US6475226B1 (en) 1999-02-03 2002-11-05 Scimed Life Systems, Inc. Percutaneous bypass apparatus and method
US6406491B1 (en) 1999-05-04 2002-06-18 Heartstent Corporation Compliant transmyocardial implant
CA2381192A1 (en) * 1999-08-04 2001-02-15 Percardia, Inc. Methods and apparatus for direct coronary revascularization
US6253768B1 (en) 1999-08-04 2001-07-03 Percardia, Inc. Vascular graft bypass
US6302892B1 (en) 1999-08-04 2001-10-16 Percardia, Inc. Blood flow conduit delivery system and method of use
US6638237B1 (en) 1999-08-04 2003-10-28 Percardia, Inc. Left ventricular conduits and methods for delivery
SE517410C2 (en) * 2000-09-20 2002-06-04 Jan Otto Solem Device and insertion device for providing a complementary blood flow to a coronary artery
AU2002211586A1 (en) * 2000-10-11 2002-04-22 Heartstent Corporation Flexible transmyocardial implant
WO2002030326A2 (en) * 2000-10-11 2002-04-18 Heartstent Corporation Transmyocardial implant with anchor element
US6602286B1 (en) * 2000-10-26 2003-08-05 Ernst Peter Strecker Implantable valve system
US6596024B2 (en) * 2000-12-21 2003-07-22 Carbomedics Inc. Polymeric heart valve fabricated from polyurethane/polysiliconeurethane blends
EP1395214B1 (en) * 2001-04-27 2014-02-26 Cormend Technologies, LLC Prevention of myocardial infarction induced ventricular expansion and remodeling
EP1592367B1 (en) * 2002-08-28 2016-04-13 HLT, Inc. Method and device for treating diseased valve
FR2846520B1 (en) * 2002-11-06 2006-09-29 Roquette Freres USE OF MALTODEXTRINS BRANCHED AS BLEACHES OF GRANULATION
US7077801B2 (en) 2003-02-19 2006-07-18 Corlife Gbr Methods and devices for improving cardiac output
IES20030531A2 (en) 2003-07-17 2005-09-21 Medtronic Vascular Connaught Methods and devices for placing a fistula device in fluid communication with a target vessel
IES20030539A2 (en) 2003-07-22 2005-05-18 Medtronic Vascular Connaught Stents and stent delivery system
US7967829B2 (en) * 2003-10-09 2011-06-28 Boston Scientific Scimed, Inc. Medical device delivery system
EP1761202A4 (en) 2004-03-23 2012-06-13 Correx Inc Apparatus and method for connecting a conduit to a hollow organ
US7799041B2 (en) * 2004-03-23 2010-09-21 Correx, Inc. Apparatus and method for forming a hole in a hollow organ
WO2006065966A2 (en) 2004-12-15 2006-06-22 Correx, Inc. Apparatus and method for connecting a conduit to a hollow vessel
DE102005003632A1 (en) 2005-01-20 2006-08-17 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Catheter for the transvascular implantation of heart valve prostheses
US8764820B2 (en) * 2005-11-16 2014-07-01 Edwards Lifesciences Corporation Transapical heart valve delivery system and method
JP4855784B2 (en) * 2006-01-16 2012-01-18 日本コヴィディエン株式会社 Gripping tool
US7896915B2 (en) 2007-04-13 2011-03-01 Jenavalve Technology, Inc. Medical device for treating a heart valve insufficiency
BR112012021347A2 (en) 2008-02-26 2019-09-24 Jenavalve Tecnology Inc stent for positioning and anchoring a valve prosthesis at an implantation site in a patient's heart
US9044318B2 (en) 2008-02-26 2015-06-02 Jenavalve Technology Gmbh Stent for the positioning and anchoring of a valvular prosthesis
JP5616891B2 (en) 2008-08-26 2014-10-29 セント ジュード メディカル インコーポレイテッドSt. Jude Medical, Inc. Method and system for sealing a percutaneous puncture
US20100191168A1 (en) * 2009-01-29 2010-07-29 Trustees Of Tufts College Endovascular cerebrospinal fluid shunt
CA2799459A1 (en) 2010-05-25 2011-12-01 Jenavalve Technology Inc. Prosthetic heart valve and transcatheter delivered endoprosthesis comprising a prosthetic heart valve and a stent
US9381082B2 (en) 2011-04-22 2016-07-05 Edwards Lifesciences Corporation Devices, systems and methods for accurate positioning of a prosthetic valve
US10130374B2 (en) 2012-05-11 2018-11-20 Michael Zhadkevich Anti-embolic device and method
US9655627B2 (en) 2012-05-11 2017-05-23 Michael Zhadkevich Anti-embolic device and method
WO2013171276A1 (en) 2012-05-16 2013-11-21 Endovascular Development AB An assembly with a guide tube, a fixator for attaching to a blood vessel, and a pump
EP2908880B1 (en) 2012-10-16 2018-12-05 Paul A. Spence Devices for facilitating flow from the heart to a blood pump
US10149757B2 (en) 2013-03-15 2018-12-11 Edwards Lifesciences Corporation System and method for transaortic delivery of a prosthetic heart valve
US9867694B2 (en) 2013-08-30 2018-01-16 Jenavalve Technology Inc. Radially collapsible frame for a prosthetic valve and method for manufacturing such a frame
US9737696B2 (en) 2014-01-15 2017-08-22 Tufts Medical Center, Inc. Endovascular cerebrospinal fluid shunt
EP3998100A1 (en) 2014-01-15 2022-05-18 Tufts Medical Center, Inc. Endovascular cerebrospinal fluid shunt system
US9808260B2 (en) 2014-05-04 2017-11-07 Zhadkevich Medical, Inc. Noninvasive protection from emboli
EP3134033B1 (en) 2014-05-29 2018-04-04 Edwards Lifesciences CardiAQ LLC Prosthesis and delivery device
US10258348B2 (en) 2015-01-27 2019-04-16 Michael Zhadkevich Devices and techniques for vascular compression
EP3288495B1 (en) 2015-05-01 2019-09-25 JenaValve Technology, Inc. Device with reduced pacemaker rate in heart valve replacement
US11103416B2 (en) 2015-09-28 2021-08-31 Michael Zhadkevich Device and method for simultaneous detection, monitoring and prevention of cerebral emboli
EP4183371A1 (en) 2016-05-13 2023-05-24 JenaValve Technology, Inc. Heart valve prosthesis delivery system and method for delivery of heart valve prosthesis with introducer sheath and loading system
WO2018138658A1 (en) 2017-01-27 2018-08-02 Jenavalve Technology, Inc. Heart valve mimicry
KR101976743B1 (en) * 2017-07-14 2019-05-09 주식회사 비씨엠 Stent insertion device for human digestive organ connection
CN108309504B (en) * 2018-02-27 2019-07-26 宁波迪创医疗科技有限公司 A kind of ventricular assist device enhancing heart function
JP7178247B2 (en) * 2018-12-03 2022-11-25 朝日インテック株式会社 Blood vessel model and organ simulator
CN114449978A (en) * 2019-08-06 2022-05-06 爱德华兹生命科学公司 In vitro cardiac bypass shunt

Citations (91)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US603856A (en) * 1898-05-10 Soda-water fountain
US3316914A (en) * 1963-02-14 1967-05-02 Michael B Collito Surgical methods and devices for anastomosis
US4011872A (en) * 1974-04-01 1977-03-15 Olympus Optical Co., Ltd. Electrical apparatus for treating affected part in a coeloma
US4368736A (en) * 1980-11-17 1983-01-18 Kaster Robert L Anastomotic fitting
US4523592A (en) * 1983-04-25 1985-06-18 Rollin K. Daniel P.S.C. Anastomotic coupling means capable of end-to-end and end-to-side anastomosis
US4562597A (en) * 1982-12-13 1986-01-07 Possis Medical, Inc. Method of supplying blood to blood receiving vessels
US4580568A (en) * 1984-10-01 1986-04-08 Cook, Incorporated Percutaneous endovascular stent and method for insertion thereof
US4581017A (en) * 1983-03-07 1986-04-08 Harvinder Sahota Catheter systems
US4728328A (en) * 1984-10-19 1988-03-01 Research Corporation Cuffed tubular organic prostheses
US4822341A (en) * 1987-11-20 1989-04-18 Impra, Inc. Vascular access fistula
US4902289A (en) * 1982-04-19 1990-02-20 Massachusetts Institute Of Technology Multilayer bioreplaceable blood vessel prosthesis
US4985014A (en) * 1989-07-11 1991-01-15 Orejola Wilmo C Ventricular venting loop
US4995857A (en) * 1989-04-07 1991-02-26 Arnold John R Left ventricular assist device and method for temporary and permanent procedures
US5078735A (en) * 1990-06-18 1992-01-07 Mobin Uddin Kazi Prosthetic grafting method for bypass surgery
US5100423A (en) * 1990-08-21 1992-03-31 Medical Engineering & Development Institute, Inc. Ablation catheter
US5106386A (en) * 1989-08-30 1992-04-21 Angelase, Inc. Catheter
US5111832A (en) * 1990-07-24 1992-05-12 Sanjeev Saksena Processes for the control of tachyarrhythmias by in vivo laser ablation of human heart tissue
US5190058A (en) * 1991-05-22 1993-03-02 Medtronic, Inc. Method of using a temporary stent catheter
US5209731A (en) * 1991-12-13 1993-05-11 Endovascular Technologies, Inc. Hand-held gun for inflating and aspirating large volume balloons
US5211624A (en) * 1991-12-09 1993-05-18 Cinberg James Z Surgical closure device method
US5275622A (en) * 1983-12-09 1994-01-04 Harrison Medical Technologies, Inc. Endovascular grafting apparatus, system and method and devices for use therewith
US5287861A (en) * 1992-10-30 1994-02-22 Wilk Peter J Coronary artery by-pass method and associated catheter
US5302336A (en) * 1987-04-16 1994-04-12 Metzeler Automotive Profiles Gmbh Method for producing molded hose branches from rubber and a hose produced by the method
US5314436A (en) * 1992-10-30 1994-05-24 Wilk Peter J Method and apparatus for performing end-to-end anastomoses
US5318527A (en) * 1992-12-22 1994-06-07 Advanced Cardiovascular Systems, Inc. Fixed wire catheter exchange device
US5380316A (en) * 1990-12-18 1995-01-10 Advanced Cardiovascular Systems, Inc. Method for intra-operative myocardial device revascularization
US5383925A (en) * 1992-09-14 1995-01-24 Meadox Medicals, Inc. Three-dimensional braided soft tissue prosthesis
US5383892A (en) * 1991-11-08 1995-01-24 Meadox France Stent for transluminal implantation
US5389096A (en) * 1990-12-18 1995-02-14 Advanced Cardiovascular Systems System and method for percutaneous myocardial revascularization
US5395349A (en) * 1991-12-13 1995-03-07 Endovascular Technologies, Inc. Dual valve reinforced sheath and method
US5397320A (en) * 1994-03-03 1995-03-14 Essig; Mitchell N. Dissecting surgical device and associated method
US5409019A (en) * 1992-10-30 1995-04-25 Wilk; Peter J. Coronary artery by-pass method
US5425705A (en) * 1993-02-22 1995-06-20 Stanford Surgical Technologies, Inc. Thoracoscopic devices and methods for arresting the heart
US5425765A (en) * 1993-06-25 1995-06-20 Tiefenbrun; Jonathan Surgical bypass method
US5488958A (en) * 1992-11-09 1996-02-06 Vance Products Incorporated Surgical cutting instrument for coring tissue affixed thereto
US5489295A (en) * 1991-04-11 1996-02-06 Endovascular Technologies, Inc. Endovascular graft having bifurcation and apparatus and method for deploying the same
US5494041A (en) * 1992-08-19 1996-02-27 Wilk; Peter J. Method for use in surgical operation
US5501698A (en) * 1994-02-14 1996-03-26 Heartport, Inc. Endoscopic microsurgical instruments and methods
US5503635A (en) * 1993-11-12 1996-04-02 United States Surgical Corporation Apparatus and method for performing compressional anastomoses
US5505725A (en) * 1990-10-30 1996-04-09 Cardiogenesis Corporation Shapeable optical fiber apparatus
US5522880A (en) * 1990-06-11 1996-06-04 Barone; Hector D. Method for repairing an abdominal aortic aneurysm
US5591226A (en) * 1995-01-23 1997-01-07 Schneider (Usa) Inc. Percutaneous stent-graft and method for delivery thereof
US5603722A (en) * 1995-06-06 1997-02-18 Quanam Medical Corporation Intravascular stent
US5613069A (en) * 1994-12-16 1997-03-18 Tony Walker Non-blocking packet switching network with dynamic routing codes having incoming packets diverted and temporarily stored in processor inputs when network ouput is not available
US5620439A (en) * 1995-06-06 1997-04-15 George S. Abela Catheter and technique for endovascular myocardial revascularization
US5713950A (en) * 1993-11-01 1998-02-03 Cox; James L. Method of replacing heart valves using flexible tubes
US5715818A (en) * 1993-11-03 1998-02-10 Daig Corporation Method of using a guiding introducer for left atrium
US5725553A (en) * 1996-02-29 1998-03-10 Moenning; Stephen P. Apparatus and method for protecting a port site opening in the wall of a body cavity
US5755682A (en) * 1996-08-13 1998-05-26 Heartstent Corporation Method and apparatus for performing coronary artery bypass surgery
US5755778A (en) * 1996-10-16 1998-05-26 Nitinol Medical Technologies, Inc. Anastomosis device
US5758663A (en) * 1992-04-10 1998-06-02 Wilk; Peter J. Coronary artery by-pass method
US5855210A (en) * 1993-02-22 1999-01-05 Heartport, Inc. Methods for performing heart surgery
US5855597A (en) * 1997-05-07 1999-01-05 Iowa-India Investments Co. Limited Stent valve and stent graft for percutaneous surgery
US5871536A (en) * 1993-11-08 1999-02-16 Lazarus; Harrison M. Intraluminal vascular graft and method
US5875782A (en) * 1996-11-14 1999-03-02 Cardiothoracic Systems, Inc. Methods and devices for minimally invasive coronary artery revascularization on a beating heart without cardiopulmonary bypass
US5879321A (en) * 1997-01-22 1999-03-09 The University Of Kentucky Research Foundation Portocaval-right atrial shunt
US5888247A (en) * 1995-04-10 1999-03-30 Cardiothoracic Systems, Inc Method for coronary artery bypass
US5888201A (en) * 1996-02-08 1999-03-30 Schneider (Usa) Inc Titanium alloy self-expanding stent
US5893369A (en) * 1997-02-24 1999-04-13 Lemole; Gerald M. Procedure for bypassing an occlusion in a blood vessel
US5893886A (en) * 1996-08-05 1999-04-13 Association Rene Leriche Vascular prosthesis
US5895407A (en) * 1996-08-06 1999-04-20 Jayaraman; Swaminathan Microporous covered stents and method of coating
US5897587A (en) * 1996-12-03 1999-04-27 Atrium Medical Corporation Multi-stage prosthesis
US5897589A (en) * 1996-07-10 1999-04-27 B.Braun Celsa Endoluminal medical implant
US5899934A (en) * 1997-01-31 1999-05-04 Medtronic, Inc Dual stent
US5904697A (en) * 1995-02-24 1999-05-18 Heartport, Inc. Devices and methods for performing a vascular anastomosis
US5938697A (en) * 1998-03-04 1999-08-17 Scimed Life Systems, Inc. Stent having variable properties
US6017352A (en) * 1997-09-04 2000-01-25 Kensey Nash Corporation Systems for intravascular procedures and methods of use
US6019788A (en) * 1996-11-08 2000-02-01 Gore Enterprise Holdings, Inc. Vascular shunt graft and junction for same
US6029672A (en) * 1998-04-20 2000-02-29 Heartstent Corporation Transmyocardial implant procedure and tools
US6030395A (en) * 1997-05-22 2000-02-29 Kensey Nash Corporation Anastomosis connection system
US6053942A (en) * 1998-08-18 2000-04-25 Heartstent Corporation Transmyocardial implant with coronary stent
US6063114A (en) * 1997-09-04 2000-05-16 Kensey Nash Corporation Connector system for vessels, ducts, lumens or hollow organs and methods of use
US6176864B1 (en) * 1998-03-09 2001-01-23 Corvascular, Inc. Anastomosis device and method
US6179848B1 (en) * 1996-07-24 2001-01-30 Jan Otto Solem Anastomotic fitting
US6190297B1 (en) * 1998-12-04 2001-02-20 Gerber Scientific Products, Inc. Apparatus for cutting and creasing sheet material
US6197050B1 (en) * 1998-09-14 2001-03-06 Heartstent Corporation Transmyocardial implant with compliance collar
US6196230B1 (en) * 1998-09-10 2001-03-06 Percardia, Inc. Stent delivery system and method of use
US6210430B1 (en) * 1996-05-17 2001-04-03 Jan Otto Solem By-pass graft
US6214041B1 (en) * 1998-01-20 2001-04-10 Heartstent Corporation Transmyocardial implant with septal perfusion
US6231587B1 (en) * 1995-10-13 2001-05-15 Transvascular, Inc. Devices for connecting anatomical conduits such as vascular structures
US20020004663A1 (en) * 1999-01-15 2002-01-10 Ventrica, Inc. Methods and devices for placing a conduit in fluid communication with a target vessel
US6352543B1 (en) * 2000-04-29 2002-03-05 Ventrica, Inc. Methods for forming anastomoses using magnetic force
US6517558B2 (en) * 1999-01-15 2003-02-11 Ventrica, Inc. Methods and devices for forming vascular anastomoses
US6537288B2 (en) * 1999-05-18 2003-03-25 Cardica, Inc. Implantable medical device such as an anastomosis device
US6719781B1 (en) * 1996-06-14 2004-04-13 Aptus Medical Inc. Catheter apparatus having an improved shape-memory alloy cuff and inflatable on-demand balloon for creating a bypass graft in-vivo
US20040077987A1 (en) * 1998-02-13 2004-04-22 Ventrica, Inc., Corporation Of Delaware Delivering a conduit into a heart wall to place a coronary vessel in communication with a heart chamber and removing tissue from the vessel or heart wall to facilitate such communication
US20040097988A1 (en) * 1999-01-15 2004-05-20 Ventrica, Inc. Methods and devices for placing a conduit in fluid communication with a target vessel
US20050043781A1 (en) * 1998-02-13 2005-02-24 Mark Foley Methods and devices providing transmyocardial blood flow to the arterial vascular system of the heart
US20050051163A1 (en) * 2000-03-04 2005-03-10 Deem Mark E. Methods and devices for use in performing pulmonary procedures
US7017581B2 (en) * 1993-02-22 2006-03-28 Boyd Stephen W Devices and methods for port-access multivessel coronary artery bypass surgery
US7041110B2 (en) * 1998-08-12 2006-05-09 Cardica, Inc. Method and system for attaching a graft to a blood vessel

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4520808A (en) 1983-03-10 1985-06-04 Stauffer Chemical Company Inhalation exposure apparatus
US5571169A (en) * 1993-06-07 1996-11-05 Endovascular Instruments, Inc. Anti-stenotic method and product for occluded and partially occluded arteries
US5327913A (en) * 1992-03-25 1994-07-12 Taheri Syde A Percutaneus cardiomyoplasty method
US5429144A (en) * 1992-10-30 1995-07-04 Wilk; Peter J. Coronary artery by-pass method
DE69633411T2 (en) 1995-10-13 2005-10-20 Transvascular, Inc., Menlo Park METHOD AND DEVICE FOR PREVENTING ARTERIAL ATTRACTIONS AND / OR FOR CARRYING OUT OTHER TRANSVASCULAR INTERVENTIONS
WO1997027898A1 (en) 1996-02-02 1997-08-07 Transvascular, Inc. Methods and apparatus for connecting openings formed in adjacent blood vessels or other anatomical structures
AU733341B2 (en) 1996-02-02 2001-05-10 Transvascular, Inc. A device, system and method for interstitial transvascular intervention
JP3336353B2 (en) 1996-04-08 2002-10-21 ザ、プロクター、エンド、ギャンブル、カンパニー Container with dropper and inner stopper
US5655548A (en) 1996-09-16 1997-08-12 Circulation, Inc. Method for treatment of ischemic heart disease by providing transvenous myocardial perfusion
US6250305B1 (en) * 1998-01-20 2001-06-26 Heartstent Corporation Method for using a flexible transmyocardial implant
US20010041902A1 (en) 1998-02-13 2001-11-15 Michael J. Lynch Anastomotic methods and devices for placing a target vessel in fluid communication with a source of blood
WO1999040868A1 (en) 1998-02-13 1999-08-19 Ventrica, Inc. Methods and devices providing transmyocardial blood flow to the arterial vascular system of the heart
US6808498B2 (en) 1998-02-13 2004-10-26 Ventrica, Inc. Placing a guide member into a heart chamber through a coronary vessel and delivering devices for placing the coronary vessel in communication with the heart chamber
US20020144696A1 (en) 1998-02-13 2002-10-10 A. Adam Sharkawy Conduits for use in placing a target vessel in fluid communication with a source of blood

Patent Citations (100)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US603856A (en) * 1898-05-10 Soda-water fountain
US3316914A (en) * 1963-02-14 1967-05-02 Michael B Collito Surgical methods and devices for anastomosis
US4011872A (en) * 1974-04-01 1977-03-15 Olympus Optical Co., Ltd. Electrical apparatus for treating affected part in a coeloma
US4368736A (en) * 1980-11-17 1983-01-18 Kaster Robert L Anastomotic fitting
US4902289A (en) * 1982-04-19 1990-02-20 Massachusetts Institute Of Technology Multilayer bioreplaceable blood vessel prosthesis
US4562597A (en) * 1982-12-13 1986-01-07 Possis Medical, Inc. Method of supplying blood to blood receiving vessels
US4581017A (en) * 1983-03-07 1986-04-08 Harvinder Sahota Catheter systems
US4581017B1 (en) * 1983-03-07 1994-05-17 Bard Inc C R Catheter systems
US4523592A (en) * 1983-04-25 1985-06-18 Rollin K. Daniel P.S.C. Anastomotic coupling means capable of end-to-end and end-to-side anastomosis
US5275622A (en) * 1983-12-09 1994-01-04 Harrison Medical Technologies, Inc. Endovascular grafting apparatus, system and method and devices for use therewith
US4580568A (en) * 1984-10-01 1986-04-08 Cook, Incorporated Percutaneous endovascular stent and method for insertion thereof
US4728328A (en) * 1984-10-19 1988-03-01 Research Corporation Cuffed tubular organic prostheses
US5302336A (en) * 1987-04-16 1994-04-12 Metzeler Automotive Profiles Gmbh Method for producing molded hose branches from rubber and a hose produced by the method
US4822341A (en) * 1987-11-20 1989-04-18 Impra, Inc. Vascular access fistula
US4995857A (en) * 1989-04-07 1991-02-26 Arnold John R Left ventricular assist device and method for temporary and permanent procedures
US4985014A (en) * 1989-07-11 1991-01-15 Orejola Wilmo C Ventricular venting loop
US5106386A (en) * 1989-08-30 1992-04-21 Angelase, Inc. Catheter
US5522880A (en) * 1990-06-11 1996-06-04 Barone; Hector D. Method for repairing an abdominal aortic aneurysm
US5078735A (en) * 1990-06-18 1992-01-07 Mobin Uddin Kazi Prosthetic grafting method for bypass surgery
US5111832A (en) * 1990-07-24 1992-05-12 Sanjeev Saksena Processes for the control of tachyarrhythmias by in vivo laser ablation of human heart tissue
US5100423A (en) * 1990-08-21 1992-03-31 Medical Engineering & Development Institute, Inc. Ablation catheter
US5505725A (en) * 1990-10-30 1996-04-09 Cardiogenesis Corporation Shapeable optical fiber apparatus
US5380316A (en) * 1990-12-18 1995-01-10 Advanced Cardiovascular Systems, Inc. Method for intra-operative myocardial device revascularization
US5389096A (en) * 1990-12-18 1995-02-14 Advanced Cardiovascular Systems System and method for percutaneous myocardial revascularization
US5489295A (en) * 1991-04-11 1996-02-06 Endovascular Technologies, Inc. Endovascular graft having bifurcation and apparatus and method for deploying the same
US5190058A (en) * 1991-05-22 1993-03-02 Medtronic, Inc. Method of using a temporary stent catheter
US5383892A (en) * 1991-11-08 1995-01-24 Meadox France Stent for transluminal implantation
US5211624A (en) * 1991-12-09 1993-05-18 Cinberg James Z Surgical closure device method
US5209731A (en) * 1991-12-13 1993-05-11 Endovascular Technologies, Inc. Hand-held gun for inflating and aspirating large volume balloons
US5395349A (en) * 1991-12-13 1995-03-07 Endovascular Technologies, Inc. Dual valve reinforced sheath and method
US5484418A (en) * 1991-12-13 1996-01-16 Endovascular Technologies, Inc. Dual valve reinforced sheath and method
US5758663A (en) * 1992-04-10 1998-06-02 Wilk; Peter J. Coronary artery by-pass method
US5494041A (en) * 1992-08-19 1996-02-27 Wilk; Peter J. Method for use in surgical operation
US5383925A (en) * 1992-09-14 1995-01-24 Meadox Medicals, Inc. Three-dimensional braided soft tissue prosthesis
US5409019A (en) * 1992-10-30 1995-04-25 Wilk; Peter J. Coronary artery by-pass method
US5314436A (en) * 1992-10-30 1994-05-24 Wilk Peter J Method and apparatus for performing end-to-end anastomoses
US5287861A (en) * 1992-10-30 1994-02-22 Wilk Peter J Coronary artery by-pass method and associated catheter
US5488958A (en) * 1992-11-09 1996-02-06 Vance Products Incorporated Surgical cutting instrument for coring tissue affixed thereto
US5318527A (en) * 1992-12-22 1994-06-07 Advanced Cardiovascular Systems, Inc. Fixed wire catheter exchange device
US5425705A (en) * 1993-02-22 1995-06-20 Stanford Surgical Technologies, Inc. Thoracoscopic devices and methods for arresting the heart
US5855210A (en) * 1993-02-22 1999-01-05 Heartport, Inc. Methods for performing heart surgery
US7017581B2 (en) * 1993-02-22 2006-03-28 Boyd Stephen W Devices and methods for port-access multivessel coronary artery bypass surgery
US5425765A (en) * 1993-06-25 1995-06-20 Tiefenbrun; Jonathan Surgical bypass method
US5713950A (en) * 1993-11-01 1998-02-03 Cox; James L. Method of replacing heart valves using flexible tubes
US5715818A (en) * 1993-11-03 1998-02-10 Daig Corporation Method of using a guiding introducer for left atrium
US5871536A (en) * 1993-11-08 1999-02-16 Lazarus; Harrison M. Intraluminal vascular graft and method
US5503635A (en) * 1993-11-12 1996-04-02 United States Surgical Corporation Apparatus and method for performing compressional anastomoses
US5501698A (en) * 1994-02-14 1996-03-26 Heartport, Inc. Endoscopic microsurgical instruments and methods
US5397320A (en) * 1994-03-03 1995-03-14 Essig; Mitchell N. Dissecting surgical device and associated method
US5613069A (en) * 1994-12-16 1997-03-18 Tony Walker Non-blocking packet switching network with dynamic routing codes having incoming packets diverted and temporarily stored in processor inputs when network ouput is not available
US5591226A (en) * 1995-01-23 1997-01-07 Schneider (Usa) Inc. Percutaneous stent-graft and method for delivery thereof
US5755775A (en) * 1995-01-23 1998-05-26 Schneider (Usa) Inc. Percutaneous stent-graft and method for delivery thereof
US5904697A (en) * 1995-02-24 1999-05-18 Heartport, Inc. Devices and methods for performing a vascular anastomosis
US5888247A (en) * 1995-04-10 1999-03-30 Cardiothoracic Systems, Inc Method for coronary artery bypass
US5620439A (en) * 1995-06-06 1997-04-15 George S. Abela Catheter and technique for endovascular myocardial revascularization
US5603722A (en) * 1995-06-06 1997-02-18 Quanam Medical Corporation Intravascular stent
US6231587B1 (en) * 1995-10-13 2001-05-15 Transvascular, Inc. Devices for connecting anatomical conduits such as vascular structures
US5888201A (en) * 1996-02-08 1999-03-30 Schneider (Usa) Inc Titanium alloy self-expanding stent
US5725553A (en) * 1996-02-29 1998-03-10 Moenning; Stephen P. Apparatus and method for protecting a port site opening in the wall of a body cavity
US6210430B1 (en) * 1996-05-17 2001-04-03 Jan Otto Solem By-pass graft
US6719781B1 (en) * 1996-06-14 2004-04-13 Aptus Medical Inc. Catheter apparatus having an improved shape-memory alloy cuff and inflatable on-demand balloon for creating a bypass graft in-vivo
US5897589A (en) * 1996-07-10 1999-04-27 B.Braun Celsa Endoluminal medical implant
US6179848B1 (en) * 1996-07-24 2001-01-30 Jan Otto Solem Anastomotic fitting
US5893886A (en) * 1996-08-05 1999-04-13 Association Rene Leriche Vascular prosthesis
US5895407A (en) * 1996-08-06 1999-04-20 Jayaraman; Swaminathan Microporous covered stents and method of coating
US5755682A (en) * 1996-08-13 1998-05-26 Heartstent Corporation Method and apparatus for performing coronary artery bypass surgery
US5755778A (en) * 1996-10-16 1998-05-26 Nitinol Medical Technologies, Inc. Anastomosis device
US6019788A (en) * 1996-11-08 2000-02-01 Gore Enterprise Holdings, Inc. Vascular shunt graft and junction for same
US5875782A (en) * 1996-11-14 1999-03-02 Cardiothoracic Systems, Inc. Methods and devices for minimally invasive coronary artery revascularization on a beating heart without cardiopulmonary bypass
US5897587A (en) * 1996-12-03 1999-04-27 Atrium Medical Corporation Multi-stage prosthesis
US5879321A (en) * 1997-01-22 1999-03-09 The University Of Kentucky Research Foundation Portocaval-right atrial shunt
US5899934A (en) * 1997-01-31 1999-05-04 Medtronic, Inc Dual stent
US5893369A (en) * 1997-02-24 1999-04-13 Lemole; Gerald M. Procedure for bypassing an occlusion in a blood vessel
US5855597A (en) * 1997-05-07 1999-01-05 Iowa-India Investments Co. Limited Stent valve and stent graft for percutaneous surgery
US6030395A (en) * 1997-05-22 2000-02-29 Kensey Nash Corporation Anastomosis connection system
US6036705A (en) * 1997-05-22 2000-03-14 Kensey Nash Corporation Anastomosis connection system and method of use
US6056762A (en) * 1997-05-22 2000-05-02 Kensey Nash Corporation Anastomosis system and method of use
US6017352A (en) * 1997-09-04 2000-01-25 Kensey Nash Corporation Systems for intravascular procedures and methods of use
US6063114A (en) * 1997-09-04 2000-05-16 Kensey Nash Corporation Connector system for vessels, ducts, lumens or hollow organs and methods of use
US6214041B1 (en) * 1998-01-20 2001-04-10 Heartstent Corporation Transmyocardial implant with septal perfusion
US20040077987A1 (en) * 1998-02-13 2004-04-22 Ventrica, Inc., Corporation Of Delaware Delivering a conduit into a heart wall to place a coronary vessel in communication with a heart chamber and removing tissue from the vessel or heart wall to facilitate such communication
US20050043781A1 (en) * 1998-02-13 2005-02-24 Mark Foley Methods and devices providing transmyocardial blood flow to the arterial vascular system of the heart
US7214234B2 (en) * 1998-02-13 2007-05-08 Medtronic, Inc. Delivering a conduit into a heart wall to place a coronary vessel in communication with a heart chamber and removing tissue from the vessel or heart wall to facilitate such communication
US5938697A (en) * 1998-03-04 1999-08-17 Scimed Life Systems, Inc. Stent having variable properties
US6176864B1 (en) * 1998-03-09 2001-01-23 Corvascular, Inc. Anastomosis device and method
US6029672A (en) * 1998-04-20 2000-02-29 Heartstent Corporation Transmyocardial implant procedure and tools
US7041110B2 (en) * 1998-08-12 2006-05-09 Cardica, Inc. Method and system for attaching a graft to a blood vessel
US6053942A (en) * 1998-08-18 2000-04-25 Heartstent Corporation Transmyocardial implant with coronary stent
US6196230B1 (en) * 1998-09-10 2001-03-06 Percardia, Inc. Stent delivery system and method of use
US6197050B1 (en) * 1998-09-14 2001-03-06 Heartstent Corporation Transmyocardial implant with compliance collar
US6190297B1 (en) * 1998-12-04 2001-02-20 Gerber Scientific Products, Inc. Apparatus for cutting and creasing sheet material
US20040097988A1 (en) * 1999-01-15 2004-05-20 Ventrica, Inc. Methods and devices for placing a conduit in fluid communication with a target vessel
US6517558B2 (en) * 1999-01-15 2003-02-11 Ventrica, Inc. Methods and devices for forming vascular anastomoses
US7025773B2 (en) * 1999-01-15 2006-04-11 Medtronic, Inc. Methods and devices for placing a conduit in fluid communication with a target vessel
US20020004663A1 (en) * 1999-01-15 2002-01-10 Ventrica, Inc. Methods and devices for placing a conduit in fluid communication with a target vessel
US6537288B2 (en) * 1999-05-18 2003-03-25 Cardica, Inc. Implantable medical device such as an anastomosis device
US20050051163A1 (en) * 2000-03-04 2005-03-10 Deem Mark E. Methods and devices for use in performing pulmonary procedures
US6719768B1 (en) * 2000-04-29 2004-04-13 Ventrica, Inc. Magnetic components for use in forming anastomoses, creating ports in vessels and closing openings in tissue
US6352543B1 (en) * 2000-04-29 2002-03-05 Ventrica, Inc. Methods for forming anastomoses using magnetic force
US7027398B2 (en) * 2001-04-12 2006-04-11 General Instrument Corporation Method and apparatus for monitoring voice conversations from customer premises equipment

Cited By (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040168691A1 (en) * 1998-02-13 2004-09-02 Sharkawy A. Adam Conduits for use in placing a target vessel in fluid communication with source of blood
US20050043781A1 (en) * 1998-02-13 2005-02-24 Mark Foley Methods and devices providing transmyocardial blood flow to the arterial vascular system of the heart
US20070233225A1 (en) * 1998-02-13 2007-10-04 Rapacki Alan R Delivering a conduit into a heart wall to place a coronary vessel in communication with a heart chamber and removing tissue from the vessel or heart wall to facilitate such communication
US8512360B2 (en) 1998-02-13 2013-08-20 Medtronic, Inc. Conduits for use in placing a target vessel in fluid communication with source of blood
US7993356B2 (en) 1998-02-13 2011-08-09 Medtronic, Inc. Delivering a conduit into a heart wall to place a coronary vessel in communication with a heart chamber and removing tissue from the vessel or heart wall to facilitate such communication
US20040097988A1 (en) * 1999-01-15 2004-05-20 Ventrica, Inc. Methods and devices for placing a conduit in fluid communication with a target vessel
US20090005852A1 (en) * 1999-01-15 2009-01-01 Gittings Darin C Methods and Devices for Placing a Conduit in Fluid Communication with a Target Vessel
US20080171101A1 (en) * 1999-09-10 2008-07-17 Rapacki Alan R Manufacturing conduits for use in placing a target vessel in fluid communication with a source of blood
US20080018016A1 (en) * 1999-09-10 2008-01-24 Rapacki Alan R Manufacturing conduits for use in placing a target vessel in fluid communication with a source of blood
US10232098B2 (en) * 2004-08-27 2019-03-19 Rox Medical, Inc. Device and method for establishing an artificial arterio-venous fistula
US20100268316A1 (en) * 2004-08-27 2010-10-21 Rox Medical, Inc. Device and method for establishing an artificial arterio-venous fistula
US20130131773A9 (en) * 2004-08-27 2013-05-23 Rox Medical, Inc. Device and method for establishing an artificial arterio-venous fistula
US11207457B2 (en) * 2004-08-27 2021-12-28 Edwards Lifesciences Corporation Device and method for establishing an artificial arterio-venous fistula
US8926545B2 (en) * 2004-08-27 2015-01-06 Rox Medical, Inc. Device and method for establishing an artificial arterio-venous fistula
US20150141899A1 (en) * 2004-08-27 2015-05-21 Rox Medical, Inc. Device and method for establishing an artificial arterio-venous fistula
US20080194939A1 (en) * 2004-09-08 2008-08-14 Advotek Medical Devices Ltd. Minimally Invasive Surgical Appartus and Methods
US10398580B2 (en) 2004-09-08 2019-09-03 Limflow Gmbh Minimally invasive surgical apparatus and methods
US11446170B2 (en) 2004-09-08 2022-09-20 Limflow Gmbh Minimally invasive surgical apparatus and methods
US20070290497A1 (en) * 2006-06-15 2007-12-20 Arendt Albert L Children's ride-on vehicles with reconfigured bodies and methods for forming the same
US10596356B2 (en) 2014-06-19 2020-03-24 Limflow Gmbh Methods for placing a stent-graft to cover collateral vessels in lower extremity vasculature
US9545263B2 (en) 2014-06-19 2017-01-17 Limflow Gmbh Devices and methods for treating lower extremity vasculature
US10543308B2 (en) 2017-04-10 2020-01-28 Limflow Gmbh Methods for routing a guidewire from a first vessel and through a second vessel in lower extremity vasculature
US11826504B2 (en) 2017-04-10 2023-11-28 Limflow Gmbh Methods for routing a guidewire from a first vessel and through a second vessel in lower extremity vasculature
US11116943B2 (en) 2018-10-09 2021-09-14 Limflow Gmbh Methods for accessing pedal veins
US11129965B2 (en) 2018-10-09 2021-09-28 Limflow Gmbh Devices and methods for catheter alignment
US11311700B2 (en) 2018-10-09 2022-04-26 Limflow Gmbh Methods for accessing pedal veins
US11478614B2 (en) 2018-10-09 2022-10-25 Limflow Gmbh Method for accessing pedal veins for deep vein arterialization
US11850379B2 (en) 2018-10-09 2023-12-26 Limflow Gmbh Devices and methods for catheter alignment
US11612397B2 (en) 2019-11-01 2023-03-28 Limflow Gmbh Devices and methods for increasing blood perfusion to a distal extremity
WO2023220119A1 (en) * 2022-05-10 2023-11-16 Abiomed, Inc. Distal limb perfusion cannula stent & stent cannula cover

Also Published As

Publication number Publication date
CA2320956A1 (en) 1999-08-19
US20030158573A1 (en) 2003-08-21
US20010025643A1 (en) 2001-10-04
AU755190B2 (en) 2002-12-05
JP2002502663A (en) 2002-01-29
AU2674699A (en) 1999-08-30
US7137962B2 (en) 2006-11-21
WO1999040868A1 (en) 1999-08-19
EP1054641A1 (en) 2000-11-29

Similar Documents

Publication Publication Date Title
US7137962B2 (en) Devices and methods for use in performing transmyocardial coronary bypass
US6808498B2 (en) Placing a guide member into a heart chamber through a coronary vessel and delivering devices for placing the coronary vessel in communication with the heart chamber
US6651670B2 (en) Delivering a conduit into a heart wall to place a coronary vessel in communication with a heart chamber and removing tissue from the vessel or heart wall to facilitate such communication
US7025773B2 (en) Methods and devices for placing a conduit in fluid communication with a target vessel
US7578828B2 (en) Methods and devices for placing a conduit in fluid communication with a target vessel
AU772615B2 (en) Methods and devices for placing a conduit in fluid communication with a target vessel
AU2003234967A1 (en) Devices and methods for use in performing transmyocardial coronary bypass
JP2002542873A (en) Method and device for forming a conduit between a target vessel and a blood source

Legal Events

Date Code Title Description
STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION